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Abstract 
Research that investigates effective assessment or treatment of conditions associated with 
physical inactivity and obesity is warranted, as these factors pose a large public health challenge.  
The first study in this thesis demonstrated that participating in physical activity (PA) even once a 
week was associated with lower all-cause mortality risk compared to no PA (P<0.05).  However, 
only in very old adults was participating in PA more than once per week associated with an even 
lower mortality risk (P<0.05).  The second and third studies determined that adults with type 2 
diabetes (T2D) or hypertension who were physically active, treated and controlled had a 
significantly lower mortality risk as those who were physically inactive, regardless of treatment 
or control (P<0.05), a similar mortality risk as adults without T2D (P>0.05), and a higher 
mortality risk compared to physically active adults without hypertension (P<0.05).  These studies 
demonstrate the importance of a higher frequency of PA in very old adults, and the benefits of 
PA on mortality risk in adults with hypertension or T2D.    
The fourth study demonstrated that adults with overweight and not attempting weight loss 
had the greatest error in estimating vigorous energy expenditure, and calories in food.  However, 
among all participants, there was a large individual error in calorie estimation.  The overall poor 
understanding of energy expended through exercise and calories in food may have important 
implications for weight management. The fifth study determined that adults consider the 
clinically recommended waist circumference (WC) measurement sites (iliac crest and midpoint) 
the most difficult sites to self-measure (P<0.05).  However, there were no differences in the 
accuracy of self-measurement, or the association between WC and blood pressure between 
measurement sites, but there were large variations in the prevalence of abdominal obesity 
between sites (0-18% for normal weight; 21-78% for overweight).  Therefore, there may be no 
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clear advantages of measuring one WC site over another.  In summary, even modest amounts of 
PA are effective for reducing mortality risk, and may be particularly beneficial in very old adults, 
and among adults with T2D or hypertension.   In addition, effective methods for long term 
weight management are needed.     
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Chapter 1. General Introduction  
 Due to rapid modernization within the past several decades, much of the world now lives 
in an “obesogenic” environment, characterized by easy access to an abundance of energy dense 
foods, and activities that require very little energy expenditure 
1
.  As a result, physical inactivity 
and obesity are highly prevalent globally and represent major public health challenges.  Physical 
inactivity and obesity have increased in all age groups, and now represent the fourth and fifth 
leading global risks for mortality 
2
.  In particular, the prevalence of T2D and cardiovascular 
disease (CVD) are expected to continue to increase in the future due to obesity, sedentary 
lifestyles 
3
 and an increasing aging population 
4
, which places a great financial burden on the 
health care system.  Therefore, safe and cost-effective management of these conditions is needed.   
Obesity is a multifactorial condition, and it is recommended that all obese persons lose 
weight 
5
.  Lifestyle interventions, such as caloric restriction and exercise, are typically the first 
line of treatment prescribed for weight loss 
5
.  Energy balance is the result of energy intake and 
energy expenditure.  Therefore, it may be important to have an understanding of both 
components of energy balance in order to successfully manage body weight 
6
.  However, even 
when significant weight loss is achieved, few obese persons are able to maintain weight loss over 
a long term 
7
.  Therefore, it is important to investigate factors that are associated with successful 
weight loss and weight management. 
Not only has general obesity increased, but so has the prevalence of abdominal obesity 
8
, 
which is an independent predictor of health and mortality risk 
9,10
. But unlike general obesity, 
methods for assessing abdominal obesity are not universally standard.   Thus, the purpose of this 
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thesis is to investigate a variety of issues associated with PA, obesity, metabolic health, and 
mortality risk in various populations that differ in age, body weight and disease status.   
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Chapter 2. Literature Review 
2. 1 Physical Activity and Health  
Physical activity is defined as any bodily movement produced by skeletal muscles that 
requires energy expenditure and increases heart rate and breathing 
11
.  Compared to less active 
individuals, adults who are physically active have a lower risk of CVD, T2D, hypertension and 
dyslipidaemia 
12
.  Physical activity is beneficial for mortality risk, as those who are active are 
reported to have a 30% lower risk of premature mortality as individuals who are physically 
inactive 
13
. Physical activity is also recommended for the prevention and management of obesity 
5
 and is important for weight maintenance following weight loss 
14
.  Even without weight loss, 
PA is associated with decreased abdominal obesity 
15
 and health risk 
16
.  
The Canadian Physical Activity Guidelines for Adults ages 18-64 years suggests that 
adults should accumulate at least 150 minutes of moderate or vigorous PA a week for health 
benefits, as well as include bone and muscle strengthening activities at least 2 days a week 
11
.  
These guidelines are similar for older adults, and also include recommendations for engaging in 
PA that enhances balance and prevents falls 
17
.  However, older adults are at a higher risk for 
health conditions that may be prevented or improved with PA than younger adults, and therefore 
it is likely that the association between PA and health may differ by age.  Furthermore, most 
studies that have assessed the association between PA and mortality risk have examined total 
energy expended, or the duration of PA 
13
, with only a paucity of studies reporting on the 
association between frequency of PA and mortality risk 
18
.  However, the few studies that have 
measured frequency of PA have demonstrated that participating in PA even once a week is 
associated with lower mortality risk 
19–22
. 
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2.2 Older Adults and Physical Activity   
In the Western world, older adults (65+ years) are a rapidly increasing segment of the 
population.  In Canada, the proportion of older adults is expected to increase from 15% to 23% 
by 2030 
4
.  Because risk of many chronic conditions increase with age, a larger older adult 
population infers a greater potential burden to the healthcare system 
23
.  Therefore, low-cost 
approaches for improving the health of older adults are needed.  In older adults, PA is associated 
with reduced risk of cardiometabolic disease, greater functional health, better cognitive 
functioning, and lower mortality risk 
13,24–26
. Despite the known health benefits of participating 
in PA in older adulthood, older adults are less likely to be physically active than younger adults 
27
.  Recent evidence suggests that in adults 60 years and older, not meeting the current PA 
guidelines is associated with a  2.8-4.9 years of life lost in normal weight, and 1.3-1.5 years of 
life lost in overweight 
28
.  Additionally, it is estimated that if everyone age 60 years and older 
met the PA guidelines, life expectancy at age 60 would increase by 1.7-3.1 years 
28
. 
Very old adults (80+ years) are a population that is expected to increase from 5.5 million 
in 2010 to 19 million by 2050 in the United States 
29
. Although research investigating PA in very 
old adults is scarce, there is evidence to suggest that PA is also strongly associated with 
improved physical functioning in this age group 
30
, as well as lower mortality risk 
31–33
.  
However, very old adults are even less likely to participate in PA compared to older adults 
34
.  
Given that PA has differential effects on the various aspects of health, the association between 
PA and mortality risk may differ by age.  In particular, older adults may be a population that 
especially benefit from PA compared to younger age groups. However, it is not known if the 
association between PA and mortality risk is consistent across the adult age span.   
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2.3 Obesity and Health  
For much of the world, daily tasks now require minimal energy expenditure, and there is 
an unprecedented availability of energy dense foods 
1
.  This has resulted in an increased 
prevalence of obesity in most developed and developing nations 
35
, including Canada where 
obesity rates have increased from 6% to 18% between 1985 and 2011 
36
.  Obesity is a significant 
risk factor for major chronic conditions, including CVD, T2D, hypercholesterolemia, 
osteoarthritis, depression, functional disability, and cognitive decline  
37–41
.  Indeed, obesity is 
now the second highest risk factor for disease in North America 
42
, and is the fifth leading cause 
of mortality globally 
2
.  Although obesity is typically associated with deleterious health 
outcomes, there is some evidence that the association between obesity and health weakens with 
increasing age 
43,44
, and that some obese sub-populations are not negatively affected by their 
weight 
45
.  Nonetheless, it is projected that obesity rates will continue to increase in the U.S., 
resulting in 6 million new cases of diabetes, and 5 million new cases of coronary heart disease 
and stroke by 2030 
46
.  Although BMI is the most widely used indicator of obesity (≥30 kg/m²), 
it does not take into account body fat distribution, and it is now established that increased 
abdominal obesity is associated with cardiometabolic health risk 
47
 and mortality risk 
10
 
independent of overall obesity 
47
.  Fat that accumulates around the abdominal cavity is 
significantly associated with increased risk for hypertension 
48,49
, impaired fasting glucose, T2D, 
and the metabolic syndrome 
50,51
.  However, unlike general obesity, there is no universal 
standard for measuring and classifying abdominal obesity.     
2.4 Waist Circumference Measurement  
  Precise measurement of abdominal fat and specific fat depots requires expensive and 
time-consuming methods, and the specific measurement site has significant influence on the 
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association between adipose tissue and metabolic risk factors 
52
.  Waist circumference is used as 
a surrogate measure of abdominal adiposity and has been demonstrated to be a good predictor of 
metabolic health risk and mortality risk 
10,53,54
.  In the United States and Canada, single sex-
specific WC thresholds are used to predict elevated health risk associated with abdominal obesity 
(≥ 102 cm for males; ≥ 88 cm for females) 55.  Several health organizations now recommend 
measuring both BMI and WC to assess weight-related health risk 
5,56,57
, including The Canadian 
Guidelines for Body Weight 
56
.        
For research and clinical purposes, there are five commonly measured WC measurement 
sites: the superior border of the iliac crest, the last rib, the midpoint between the iliac crest and 
last rib, the minimal waist, and the umbilicus 
58
.  Currently, there is no universally accepted WC 
measurement location, with various health agencies recommending WC measurement at 
different sites.    For example, the World Health Organization and the International Diabetes 
Federation recommend measurement at the midpoint, the National Institutes of Health and 
Health Canada recommend WC measurement at the iliac crest 
56,57
, the American College of 
Sports Medicine recommends measurement at the minimal waist 
59
, and the Japanese Metabolic 
Syndrome Guidelines recommend measurement at the umbilicus 
60
.   
Waist circumference measured at different measurement sites has been reported to 
influence the absolute magnitude of WC, particularly for females 
61,62
.  Waist circumference 
tends to be typically largest at the umbilicus and iliac crest, and smallest at the last rib and 
minimal waist 
63
.  These differences will in turn also influence the proportion of individuals 
classified as having a high WC when the same dichotomous WC threshold values are used to 
predict health risk.  One study reported that up to 10% more females were classified as having a 
high WC when waist was measured at the iliac crest (recommended site by Health Canada) 
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compared to the midpoint (recommended site by the World Health Organization) 
64
.  
Furthermore, there is some evidence that WC measurement site may significantly influence the 
association between WC and cardiometabolic risk factors 
62,65,66
.  However, whether or not 
individuals can accurately self-measure their own WC at the various WC measurement sites is 
not clear, and it is not known if individuals consider any site(s) to be easier or more difficult to 
measure.  This information would be important to know if public health agencies wish to 
promote self-measurement of WC to assess health risk. 
2.5 Physical Activity and Weight Management  
 Physical activity is a recommended lifestyle treatment for overweight and obesity 
5
.  In 
the United States, approximately 50% of adults are attempting to lose weight, with caloric 
restriction and exercise being the most common methods of weight loss 
67
.   For weight loss to 
occur, caloric expenditure must exceed caloric intake in order for there to be a sustained negative 
energy balance 
68
.  It has been suggested that exercise without caloric restriction is a modest 
means for reducing obesity 
69
.  However, most evidence would suggest that a combination of 
both exercise and caloric restriction is more beneficial for short term weight loss as well as 
weight loss maintenance compared to PA alone due to the low levels of PA energy expenditure 
typically prescribed in research studies 
70,71
.  Although the weight loss observed with PA is 
related to the total energy expended through exercise 
69
, there is a large variability in individuals 
weight loss in response to exercise due to differences in compensation of energy intake 
72
.  This 
would indicate that to manage body weight, an individual may need to understand how to 
manage both energy expenditure and energy intake 
6
.   
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2.6 Calories and Weight Management 
A recent meta-analysis of behavioural weight management programs in overweight and 
obese adults demonstrated that programs that encouraged patients to count calories were 
associated with the greatest amount of weight loss (3.3 kg) at 12 months 
73
. Although energy 
balance is a product of energy intake and energy expenditure, there are a limited number of 
studies that have actually investigated whether or not individuals are accurate at estimating 
calories, and whether accuracy is associated with obesity or weight loss status.  For example, 
Carels et al. (2007) reported that dieters were significantly more accurate at estimating calories 
in various types of common foods compared to non-dieters, although the mean difference 
between the groups was only 16 kcals (14%) 
74
.  Visona and George (2002) observed that 
regardless of level of dietary restraint, overweight women who were dieting underestimated 
energy expenditure by 81 kcal, whereas those who were not dieting overestimated energy 
expenditure by 121 kcal, after one hour of moderate intensity exercise.  However, both groups 
underestimated the amount of calories consumed in an ad libitum post-exercise meal by ~75 kcal 
75
. A similar investigation in males reported that overall there was a tendency to overestimate 
moderate intensity exercise expenditure by 129 kcal, and underestimate a post-exercise meal by 
435 kcal.  Although dieting status was not reported, males with high dietary restraint were more 
accurate at estimating exercise energy expenditure compared to males with low dietary restraint, 
although both groups underestimated caloric content of an ad libitum post-exercise meal 
76
.  
However, in both of the aforementioned studies, exercise energy expenditure was estimated 
using predictive equations, which has been suggested to be less precise than using indirect 
calorimetry 
77
. 
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Whether or not there is a difference in accuracy of calorie estimation by weight status is 
also unclear.  It was reported that obese individuals with a history of weight loss failure under 
reported energy intake, and over reported physical activity, by approximately 50% 
78
.  Similarly, 
obese individuals who were dieting underestimated the caloric content of common types of foods 
by 53% 
79
.  Further, there is evidence that calorie estimation may depend on the perceived 
“healthfulness” of foods, as individuals with obesity who were undergoing a behavioural weight 
loss intervention underestimated the caloric content of “healthy” food, and overestimated the 
caloric content of “unhealthy” food.    However, in all types of food, absolute error in calorie 
estimation increased with increasing BMI 
80
.  Conversely, others have reported that normal 
weight and overweight individuals have a similar ability to estimate calories 
74,76
.  
Although energy balance is the result of both energy intake and expenditure, only two 
studies have investigated how accurate individuals are at estimating exercise energy expenditure 
and caloric content of food with the intent of replacing calories lost during exercise.  Willbond 
(2010) demonstrated that moderate intensity exercise expenditure was overestimated by 300-
400%, whereas post-exercise energy intake was underestimated by 200-300% in normal weight 
males and females 
81
.  Conversely, Holliday (2014) reported that normal weight adults 
underestimated moderate intensity exercise expenditure, and accurately estimated vigorous 
intensity exercise expenditure. Post-exercise energy consumption was similar to actual energy 
expenditure in both exercise conditions 
82
.  However, neither of these studies investigated 
overweight or obese individuals, and weight loss status of the participants was not reported.  
Thus, it is not clear how body weight class, or weight loss status influences estimation of 
moderate and vigorous exercise energy expenditure, or calories in food.   
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2.7 Type 2 Diabetes Management   
Overall obesity, and specific fat depots, such as in the abdomen and the liver, are all 
independently associated with risk for insulin resistance 
83
. Insulin is a hormone produced in the 
pancreas that helps lower blood glucose by allowing muscle, liver, and fat cells to absorb glucose 
from the blood stream 
84
.  When insulin attaches to its receptor, it stimulates the translocation of 
the GLUT4 transporter to the plasma membrane, and glucose is transported into the cell 
85
.  
Insulin resistance is a condition in which cells do not respond properly to insulin and therefore 
glucose uptake into the cells is impaired 
84
.  Although the exact mechanism is not yet established, 
obesity may cause insulin resistance via a number of pathways, including direct drainage of fatty 
acids from the abdomen into the portal system, the impairment of insulin-mediated glucose 
uptake by fatty acids in non-adipose tissue, as well as the modulation of insulin action by 
adipocytokines that are released from adipose tissue 
86
.  Type 2 diabetes is a chronic metabolic 
disorder characterized by insulin resistance and the presence of hyperglycemia 
87
.  Type 2 
diabetes is diagnosed by either fasting plasma glucose ≥ 7.0 mmol/L, HbA1c ≥ 6.5%, 2-hour 
plasma glucose from an oral glucose tolerance test ≥ 11.1 mmol/L, or random plasma glucose ≥ 
11.1 mmol/L 
87
.  Type 2 diabetes is a major risk factor for heart disease, stroke and kidney 
failure, and is the leading cause of lower limb amputation, and new cases of blindness in adults 
87
. In Canada, from 1999 to 2009, the prevalence of diabetes increased 70% , with approximately 
9% of Canadian adults now living with T2D, and an estimated  20% of cases remaining 
undiagnosed 
90
.  A slightly higher proportion of U.S. adults (11.3%) have diagnosed T2D 
88
.   
Management of T2D has improved in the United States, from only 35% of adults with 
T2D having glycemic control in 1999 to 55% in 2010 
91
.   The cornerstone of T2D management 
is to achieve and maintain blood glucose control (HbA1c of <7.0%), which can be achieved 
11 
 
through a combination of a healthy diet, PA, weight loss, and antihyperglycemic medication 
92,93
.  
According to the Canadian Diabetes Association, adults with T2D should not consume more than 
7% of daily energy intake from saturated fat, or more than 10% of daily energy intake from 
added sucrose or fructose, and should choose carbohydrates with a low glycemic index 
94
.  It is 
also recommended that adults with T2D engage in a minimum of 150 minutes of moderate to 
vigorous aerobic PA a week, with at least 2 days a week of resistance training.  Due to the acute 
insulin sensitizing effect of exercise 
95
, adults with T2D should not go more than two consecutive 
days without exercise 
94
.   Indeed, although insulin-dependent blood glucose uptake at rest is 
impaired in T2D, muscular contractions during exercise are still able to stimulate blood glucose 
transport into skeletal muscles via insulin-independent mechanisms 
96
.  There is evidence that 
increased blood glucose uptake by the muscle persists for several hours post exercise, and that 
PA can result in acute improvements in systemic insulin action lasting from 2 to 72 hours post 
activity 
96
. A recent meta-analysis reported that structured exercise training is associated with an 
overall 0.67% reduction in HbA1c compared to controls 
97
.  Other benefits of PA for individuals 
with T2D include weight loss, and reductions in LDL cholesterol and systolic blood pressure 
96
.   
Physical activity has also been associated with lower premature mortality risk in adults 
with T2D 
98–101
.  There is evidence that participating in PA at least 3 times/week is associated 
with lower all-cause and CVD mortality risk compared to participating in less PA 
102
.  Even 
participating in some PA but not enough to meet the recommended PA guidelines is associated 
with significantly lower morality risk compared to participating in no activity 
103
.  Still, there is 
evidence that participating in PA even once a week is associated with a significantly lower risk 
of cardiovascular events, microvascular events, and mortality risk in adults with T2D  
104,105
.  
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Moreover, physically active adults with T2D were reported to have a similar mortality risk as 
physically inactive adults without T2D 
106
.  
When T2D cannot be managed with lifestyle change alone, antihyperglycemic therapy is 
typically prescribed.  Approximately 84% of adults with T2D manage their disease with 
medication 
88
. Antihyperglycemic agents act by either slowing digestion of carbohydrates (alpha-
glucosidase inhibitors),  increasing insulin secretion (DPP-4 inhibitors, GLP-1 receptor agonists, 
sulfonylureas and meglitinide), increasing peripheral glucose uptake (insulin, metformin and 
TZDs), or decreasing hepatic glucose output (insulin, metformin and TZDs) 
90
.  Metformin is 
typically the initial drug prescribed due to evidence that it is effective in lowering blood glucose, 
associated with relatively few side effects, has a low risk of causing hypoglycemia, and is weight 
neutral 
90
.   Despite the ability of insulin and sulfonylureas to also be effective for lowering blood 
glucose, both are associated with weight gain and a higher risk of hypoglycemia compared to the 
other drug classes.  As well, some studies report that rosiglitazaone (TZD) is associated with 
increased risk of congestive heart failure, fractures, and myocardial infarction 
90
.   
   The association between antihyperglycemic therapy and glycemic control on mortality 
risk is not established.  For example, achieving glycemic control has been associated with lower 
mortality risk in adults with T2D 
107,108
, yet there is evidence that intensive glucose lowering 
therapy may lead to increased mortality risk 
109,110
.  There is also evidence that some 
antihyperglycemic medications may be associated with increased mortality risk despite 
improving glucose control 
111,112
. Of the TZD drug class, rosiglitazone has been associated with 
an increased mortality risk compared to pioglitazone 
111
, as well as other classes of 
antihyperglycemic agents 
112
.  It has also been suggested that sulphonylureas may be associated 
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with an increased mortality risk 
113,114
. There is also inconsistent evidence as to whether adults 
with controlled T2D have a similar mortality risk as adults without T2D 
106,115–117
.   
Thus, in adults with T2D, PA is associated with lower HbA1c and mortality risk 
102
.  
Although most medications for T2D are associated with improved glycemic control, intensive 
glucose lowering treatment, and some T2D medications, have been associated with higher rates 
of hypoglycemia and mortality 
90,110,111
.   However, the joint association between PA, 
antihyperglycemic medication, and glycemic control on mortality risk in adults with and without 
T2D is not known.   
2.8 Hypertension Management  
Obesity is also a significant risk factor for hypertension 
37
.  Hypertension is a chronic 
disease that is characterized by a high pressure of blood in the arteries (≥140/90 mmHg), and is a 
significant risk factor for heart disease and stroke 
89
.  The prevalence of hypertension is 
estimated to be 22% in Canadian adults 
118
 and 30% in U.S. adults 
119
.  During the past two 
decades in the United States and Canada, the prevalence of hypertension has remained stable, 
although the proportion of adults treated with antihypertensive therapy, and those that obtained 
blood pressure control, has significantly improved 
89,118
.  Despite a higher proportion of adults 
with hypertension receiving antihypertensive treatment and obtaining blood pressure control, 
hypertension is still the leading risk factor for disease burden globally 
2
, and the fourth leading 
risk factor for disease burden in North America 
42
.   
The goal of hypertension management is to attain and maintain blood pressure control 
(<140/90 mmHg), which can be achieved through lifestyle changes and pharmacotherapy 
120
.  
Non-pharmacological treatments, such as diet and PA, are the first line of treatment for patients 
with hypertension 
120
.  According to the Canadian Hypertension Education Program guidelines, 
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adults with hypertension are advised to consume a diet that is high in fruits, vegetables, whole 
grains, lean meats, and low-fat dairy, to limit foods high in saturated fat and cholesterol, and to 
consume no more than 2000 mg of sodium/day 
121
.  They also recommend engaging in moderate 
or vigorous PA for 30-60 minutes 4-7 days/week 
121
.  Physical activity in adults with 
hypertension is associated with lower blood pressure, reduced adiposity and inflammation, 
enhanced endothelial function, improved baroreflex sensitivity, regression of left ventricular 
hypertrophy, blood glucose control, improved lipid profile, and lower risk of cardiovascular 
events 
122,123
.  In middle-aged and older males with hypertension, a single 45 minute bout of 
aerobic exercise reduced systolic blood pressure by up to 13 mmHg 16 hours post-exercise, with 
an average reduction of 7.3 mmHg 24 hours post-exercise 
124
.  Furthermore, chronic aerobic 
exercise lasting at least 4 weeks is associated with an average reduction of 6.9/4.9 mmHg in 
adults with hypertension, likely due to a decrease in systemic vascular resistance 
125
. 
Participation in regular moderate or vigorous activity is also associated with significantly lower 
cardiovascular and all-cause mortality risk, even after adjusting for blood pressure 
126
 or  
antihypertensive treatment 
127
.  Even a modest amount of PA of at least twice a week for 30 
minutes was associated with a 35% lower risk of all-cause mortality, and new-onset diabetes in 
adults with hypertension 
128
. 
When high blood pressure cannot be managed with lifestyle change alone, 
antihypertensive therapy is typically prescribed.  Pharmacotherapy for hypertension is often 
referred to as one of the major successes of modern medicine 
129
, and approximately 76% of 
adults with hypertension take antihypertensive medication to help manage their disease 
89
.  
Antihypertensive agents typically lower blood pressure by either decreasing extracellular fluid 
and blood volume (thiazide diuretics), causing vasodilation of vasculature (calcium channel 
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blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers), reducing 
heart rate and cardiac output (beta-blockers), or by reducing total peripheral resistance (alpha-
adrenergic blockers)  
130–132
.  Beta-blockers and alpha-blockers are not recommended for initial 
treatment because they have been associated with higher risk of cardiovascular events compared 
to the use of initial therapy with an angiotensin receptor blocker 
133
, and a diuretic 
134
, 
respectively.  A meta-analysis of different blood pressure lowering regimens concluded that any 
common antihypertensive medication was associated with reduction in risk of CV events 
compared to placebo 
135
, however, it is uncertain if pharmacological treatment of hypertension is 
also associated with lower risk of premature mortality 
129
. 
Studies investigating the association between antihypertensive treatment and blood 
pressure control on mortality risk show equivocal results 
136–140
.  A recent systematic review that 
investigated the effects of antihypertensive treatment on adults with mild hypertension (systolic 
blood pressure 140-160 mmHg or diastolic blood pressure 90-100 mmHg) found that treatment 
for 5 years did not reduce coronary heart disease, stroke, or total cardiovascular events compared 
to placebo 
141
.  Interestingly, in over 10 years of follow-up in the Reykjavik Study, males with 
untreated hypertension had a lower risk for myocardial infarction, CVD, and all-cause mortality 
compared to males with treated hypertension, with no differences between treated and untreated 
females 
142
.  Conversely, data from NHANES indicates that adults with hypertension who are 
treated and uncontrolled, and untreated and uncontrolled, had a 57% and 34% higher all-cause 
mortality risk, respectively, compared to adults with hypertension who are both treated and 
controlled 
137
.  However, PA, which is also associated with lower mortality risk in hypertension 
143
, was not assessed.   
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Thus, PA is associated with lower blood pressure and mortality risk in adults with 
hypertension.  Although antihypertensive therapy is associated with improved blood pressure 
control, the association between antihypertensive therapy and blood pressure control on mortality 
risk is not consistent.  As well, the joint association between PA, antihypertensive therapy, and 
blood pressure control is not known.   
2.9 Summary, Objectives and Hypotheses  
In summary, although PA is associated with improved health outcomes and lower 
mortality risk in all age groups 
144
, it is not known if the association between PA and mortality 
risk is consistent across the adult age span.  For both T2D and hypertension, PA and 
pharmacotherapy are recommended to help achieve blood glucose control 
90
, and blood pressure 
control 
121
, respectively.  However, the joint association of PA, pharmacotherapy, and metabolic 
control on mortality risk is not known for either disease.  Physical activity is also recommended 
for weight loss and weight maintenance 
14
, and in order to manage weight one should be able to 
accurately estimate exercise energy expenditure and energy intake 
6
.  Despite the potential 
importance of calorie estimation for weight management, whether or not the ability to accurately 
estimate calories during exercise and in food is influenced by BMI, weight loss status, or 
exercise intensity, is not known.  Finally, although BMI is the most widely used indicator of 
obesity, WC is now established as a simple and reliable measure of health risk independent of 
overall obesity 
9
.  Yet, there is currently no universal WC measurement landmark, it is not clear 
whether adults are able to accurately self-measure their WC at common WC measurement sites, 
and  it is not known which WC measurement sites adults naturally measure, or find easiest or 
most difficult to measure.  Therefore, the objectives of this dissertation were:  
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Objective 1:  To determine if the association between frequency of weekly PA and mortality risk 
differs among middle-aged, old, and very old adults. 
Hypotheses: A) Physical activity 1-2 times per week will be associated with a lower all-cause 
mortality risk compared to no PA in all age groups.  B) In old and very old adults, a higher 
frequency of PA will be associated with a lower mortality risk compared to a lower frequency of 
PA.   
Objective 2: To determine the joint association between PA, antihyperglycemic therapy, and 
blood glucose control on cardiovascular and all-cause mortality risk in adults with and without 
T2D.  
Hypotheses: A) Adults with T2D who are physically active, treated, and controlled will have a 
lower mortality risk compared to physically inactive adults regardless of treatment or control.  B) 
Adults with T2D who are physically active, treated, and controlled will have a higher mortality 
risk compared to adults without T2D.   
Objective 3:  To determine the joint association of PA, antihypertensive treatment, and blood 
pressure control on all-cause mortality risk in adults with and without hypertension.   
Hypotheses:  A) Adults with hypertension who are physically active, treated, and controlled will 
have a lower all-cause mortality risk compared to adults with hypertension who are physically 
inactive regardless of antihypertensive treatment or blood pressure control.  B) Adults with 
hypertension who are physically active, treated, and controlled will have a higher mortality risk 
compared to adults without hypertension.   
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Objective 4:  To determine if body weight class, weight loss status, or exercise intensity is 
associated with accuracy of estimated exercise energy expenditure, and calories in a meal.     
Hypotheses: A) Regardless of body weight class or weight loss status, all adults will 
overestimate vigorous intensity exercise energy expenditure to a greater extent than moderate 
intensity exercise energy expenditure.  B)  Regardless of body weight class or weight loss status, 
all adults will underestimate calories in a meal.  C) Adults who are overweight and not 
attempting weight loss will have a greater error in calorie estimation compared to normal weight 
adults who are and are not attempting weight loss, and overweight adults who are attempting 
weight loss.   
Objective 5: To determine A) If normal weight and overweight/obese adults are willing to self-
measure their WC, B) Which WC measurement site(s) adults naturally measure, C) Which WC 
site(s) adults find easiest or hardest to self-measure, D) If adults are able to accurately self-
measure their WC at five common WC measurement sites, and E) If the association between WC 
and blood pressure differs according to WC measurement site.   
Hypotheses:  A) The majority of adults will not be willing to self-measure their WC, B) Adults 
will naturally measure their WC most often at the umbilicus, C) Adults will find the midpoint the 
most difficult site to self-measure, D) Overweight and obese adults will be less accurate at self-
measuring their WC compared to normal weight adults, and E) The association between blood 
pressure and WC will not be influenced by WC measurement site.  
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Abstract 
Objectives: To determine if the association between frequency of leisure-time PA and mortality 
risk differs across adulthood.  Methods:  9249 adults from the NHANES III (1988-1994) were 
categorized as middle-aged (40-64y), old (65-79y) or very old (≥80y), and as inactive (0 bouts of 
physical activity/week), lightly active (1-2 bouts/week), moderately active (3-4 bouts/week) or 
very active (5+ bouts/week).  Results: In all age categories, lightly, moderately, and very active 
adults had a lower mortality risk compared to inactive adults (p<0.001).  In very old adults only, 
being very active was associated with a lower mortality risk compared to being lightly active 
(HR 0.80, 95% CI 0.64-0.98; p=0.03) and moderately active (HR 0.80, 95% CI 0.65-0.98; 
(p=0.03).   Discussion: The association between PA frequency and mortality risk is strongest in 
very old adults.  All adults and particularly very old adults may benefit from participating in PA 
five or more times a week.   
 
Key Words: Aged, 80 and over; Leisure Activities; Survival; Age Groups  
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Introduction 
Physical activity is associated with many health benefits, including decreased risk of 
CVD, T2D, hypertension, dyslipidaemia, and lower mortality risk 
13
.  Active individuals have 
been reported to have a 30% lower mortality risk during follow-up compared to inactive persons, 
with inverse associations between PA and mortality risk also being observed in the older adult 
population (Physical Activity Guidelines Advisory Committee, 2008), and a handful of studies 
demonstrating this association in very old adults 
31–33
. Many studies that have examined the 
relationship between PA and mortality risk have looked at volume of PA, and there is a paucity 
of studies that have directly examined the association between frequency of PA and mortality 
risk 
18
.  Prior studies that have looked at PA frequency have reported that in older adults, 
participation of PA once or just a few times a week is associated with lower mortality risk 
compared to being physically inactive 
19,20
.  Although few studies have examined the association 
between PA and mortality risk at different stages of adulthood, those that have generally show 
that PA is associated with lower mortality risk in both younger and older adults 
24,25
.  However, 
prior research only compared low to high PA, and did not include a very old age group, which is 
a population that is expected to steadily increase 
29
.   Individuals of various ages are at risk for 
different health problems, and because PA has differential effects on the various aspects of 
health, the association between PA and mortality risk may differ by age.  In particular, PA is 
strongly associated with improved physical functioning in very old adults 
30
, a factor that is 
important for this age group.  Thus, older adults may be a population that particularly benefit 
from participating in PA compared to younger age groups. Therefore, the objective of this study 
was to determine if the association between the frequency of PA and mortality risk differs among 
middle-aged, old and very old adults. 
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Methods 
Participants  
Data for the NHANES III was collected on a national sample of 33, 994 individuals’ aged 
two months and older in the United States between 1988 and 1994.  A detailed explanation of the 
data collection methods has been previously reported 
145,146
. Mortality information for NHANES 
III survey participants was provided by the National Centre for Health Statistics using 
probabilistic record matching with death certificate data found in the National Death Index 
(NCHS Linked Mortality File) through December 31, 2006. All survey participants gave written 
informed consent prior to participation, and the methods were approved by the National Centre 
for Health Statistics.  Subjects were excluded from this analysis if they were younger than 40 
years old, died within the first year after they were sampled, or had missing information for PA, 
CVD, T2D, or lipid medications, doctor’s diagnosis of CVD or T2D, BMI, self-rated health 
status, or self-reported mobility impairment. The final sample size was 9,249.   
Questionnaires and Physical Examination  
Monthly PA was assessed with questionnaires.  Participants were asked if they performed 
the following activities in the last month: walking one mile without stopping, biking, jogging, 
swimming, dancing, aerobics, calisthenics, gardening, and weight lifting.  They could also list up 
to four additional activities.  Information on the monthly frequency of the activity as well as the 
intensity of the activity was recorded, and each activity was assigned a metabolic equivalent 
value. Only activities that were at least a moderate intensity (metabolic equivalent ≥ 3), for 
example walking or gardening, were included in the analysis.  Activity was divided into inactive 
(0 bouts/week), lightly active (1-2 bouts/week), moderately active (3-4 bouts/week) and very 
active (5 or more bouts/week).  Questionnaires were also used to assess age, sex, education (less 
23 
 
than high school, high school, more than high school), ethnicity (white or non-white), smoking 
status (past smoker, current smoker, never smoker), BMI based on self-reported height and 
weight, medications (CVD, T2D, lipid), self-reported doctor’s diagnosis of hypertension, heart 
attack, stroke, congestive heart failure and T2D, as well as self-reported health status and 
mobility impairment.   
Age was classified into: middle-aged (40-64 years), old (65-79 years), and very old (80+ 
years).  Participants were classified as having CVD if they reported a diagnosis of hypertension, 
heart attack, stroke, or congestive heart failure, if they were taking any CVD medications or 
blood pressure medications, or if they had a systolic blood pressure ≥140 mmHg or a diastolic 
blood pressure ≥90 mmHg.  Participants were classified as having T2D if they reported a 
doctor’s diagnosis of T2D, if they reported taking diabetes medications, or if they had a fasting 
blood glucose level of ≥7.0 mmol/L.  Participants were considered dyslipidaemic if they reported 
taking any lipid medications, if fasting total cholesterol was ≥6.2 mmol/L, or if fasting 
triglycerides were ≥2.3 mmol/L.   Self-rated health status was reported as excellent, very good, 
good, fair, or poor.   Participants were classified as having a mobility impairment if they reported 
any difficulty with walking from room to room on one level, rising from an armless chair, or if 
they reported using any device to help them move, such as a cane, walker, or wheelchair.   
Statistical Analyses 
One-way analysis of variance was used to assess baseline differences between activity 
groups with inactive as the referent with Bonferroni-adjusted post-hoc analyses.  Chi-square tests 
were used to assess baseline group differences in the categorical variables.   Linear and logistic 
regressions were used to assess trends for differences in subject characteristics across PA levels 
within each age category and across age categories within each PA level.  Hazard ratios for 
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group differences in mortality risk were estimated by Cox proportional hazard analyses for all 
ages combined in order to explore interactions between PA, age and sex, and for all age 
categories separately to determine relative mortality risk within an age group.  Bonferroni 
adjustments were used for all post hoc comparisons.  The first multivariable model was adjusted 
for age, sex, education, ethnicity, and smoking status, and the final fully adjusted model included 
these variables in addition to CVD, T2D, dyslipidaemia, BMI, self-reported health status, and 
mobility impairment.   All analyses were sample weighted to be representative of the US 
population and were performed using SAS version 9.2 (SAS Institute, Cary, North Carolina).  
Statistical significance was considered at P < 0.05.   
Results 
 
Subject characteristics are presented in Table 3.1 stratified by PA level and age category.  
More women were inactive than men within all age groups.  There were no differences in the 
prevalence of dyslipidaemia across physical activity groups within each age category.  There was 
a trend for higher prevalences of CVD, T2D, and mobility problems with decreasing PA level at 
all ages (Ptrend <= 0.001).  Body mass index decreased with increasing PA level within all age 
groups (Ptrend <= 0.001).  For all ages, self-rated health tended to be good or excellent with 
increasing levels of PA, and fair or poor with decreasing levels of PA (Ptrend <= 0.001).  There 
was a trend for higher prevalence of CVD, T2D, mobility impairment, and white ethnicity with 
increasing age within each PA level (Ptrend <= 0.001).  Education level, BMI, and self-rated 
health declined with age within each PA level (Ptrend <= 0.001).   
During the follow-up of 12.1 ± 4.5 years, there were 3,738 deaths (40%).  Results for the 
first multivariable model and the fully adjusted second model were similar, thus results are only 
presented for the fully adjusted model.  In the analysis with all ages combined, age and PA level 
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were both independently associated with mortality risk (P < 0.001).  There was no significant 
interaction between sex and activity level (P = 0.86), however there was a significant age by PA 
level interaction for mortality risk (P = 0.04). Thus, when stratified by age category, lightly 
active (middle-aged: HR 0.71, 95% CI 0.54-0.94; old: 0.77, 0.63-0.93; very old: 0.73, 0.59-0.90; 
P < 0.05), moderately active (middle-aged: 0.59, 0.81-0.86; old: 0.81, 0.67-0.97; very old: 0.73, 
0.58-0.92; P < 0.05), and very active individuals (middle-aged: 0.72, 0.55-0.96; old: 0.73, 0.60-
0.89; very old: 0.59, 0.47-0.73; P < 0.05) had a lower mortality risk compared to inactive within 
each age category (Figure 3.1).   In the very old adults only, very active also had a lower 
mortality risk compared to lightly active (0.80, 0.64-0.99; P = 0.03) and moderately active (0.80, 
0.65-0.98; p = 0.03) (Figure 3.1).    
Discussion 
We observed that in a nationally representative U.S. sample of middle-aged, old, and 
very old adults, participating in moderate-vigorous PA one time a week or more is associated 
with a lower mortality risk compared to being completely inactive.  However, this is the first 
study to show that very old adults who participate in moderate-vigorous PA five or more times 
per week have a significantly lower mortality risk compared to very old adults who are 
physically active but participate in a lower frequency of PA.  Thus, in agreement with the 
previous PA guidelines, these results suggest that all adults and in particular very old adults 
should be encouraged to participate in PA five or more times/week.   
Despite the known health benefits of regularly participating in PA, in 2008, ~25% of the 
overall US adult population and ~32% of U.S. older adult population participated in no leisure 
time PA 
147
.  Physical inactivity is a known contributor to many chronic diseases in older 
Americans including vascular disease, T2D and some forms of cancer 
34
, and medical costs are 
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higher for inactive adults than active adults 
148
.  Accordingly, adults who meet the 2008 Physical 
Activity Guidelines have a lower mortality risk compared to adults who did not meet the 
guidelines 
149
.  However, one study reported that older adults who were physically active even 
once per week were at a lower mortality risk compared to inactive older adults 
19
.  Our study 
confirms these observations by demonstrating that even very low levels of PA are associated 
with lower mortality risk in all adults, but extends these findings in that engagement in higher 
frequencies of PA is associated with even lower mortality risk in adults 80 years or older.  
Beneficial effects of PA on mortality risk in very old adults have been observed in several other 
studies 
30,150,151
.  Among individuals without heart disease, the volume of PA is associated with a 
greater benefit on mortality risk for adult’s ≥ 75 years, compared to those < 75 years 152.  Due to 
the natural deterioration of health that is associated with aging, older adults are much more likely 
to be at risk for health problems which may be preventable by PA (i.e. vascular disease, diabetes, 
respiratory disease and cancer).  Together, this suggests that being physically active in late 
adulthood may be associated with greater declines in mortality risk than being physically active 
in early or middle adulthood.  
Although the present analysis was able to assess PA levels using intensity and frequency 
of PA, information on duration of activity was not available.  The volume of PA is most 
commonly used to prescribe PA 
147
, and the most current guidelines no longer give a 
recommended frequency for PA.  In the present study, a frequency of PA of five times a week or 
greater was associated with a 27% lower mortality risk for very old adults.  Although we cannot 
discount that the beneficial effect of a higher PA frequency is due to a higher volume of PA, 
there is evidence that elderly men who expend the recommended ≥ 1000 kcal/week in just one or 
two days (“weekend warriors”) still have a higher mortality risk compared to those who 
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accumulate ≥ 1000 kcal/week but are regularly active throughout the week 153.  Additionally, it 
has been reported that even one acute bout of exercise can significantly reduce blood pressure up 
to 16 hours, blood glucose for several days, and triglycerides up to 72 hours post exercise, with 
the effects usually being greatest in high risk or diseased populations 
95
.  Thus, a higher 
frequency of PA may make it more likely that the individual chronically benefits from the acute 
effects of PA.  Therefore, at least in older adults, frequency of PA perhaps should be considered 
when prescribing PA. 
Despite findings that adults ≥ 80 years can benefit from PA, there is evidence that very 
old adults participate in less PA than middle-aged and old adults 
154
.  Older adults may have 
additional barriers that prevent them from exercising, such as a greater number of co-morbidities 
155
, fear of injury 
156
, and they may not agree with some of the PA recommendations 
157
.  Thus, 
the issue of addressing the higher rates of physical inactivity in this age group may be more 
complex than other populations.   
 Several limitations of this analysis warrant mention.  This study used prospective 
observational data and therefore no causal relationships can be determined.  It may be that adults 
who did not participate in any activity were in poorer health to begin with, which was evident by 
the higher prevalence of co-morbidities, lower self-reported health, and higher mobility 
impairment in the inactive groups at any age.  However, it is important to note that even after 
accounting for the effect of poor health by adjusting for common metabolic health disorders 
(CVD, T2D and dyslipidaemia) as well as self-rated health status and mobility impairment, the 
significant association between PA and a decreased mortality risk was still present.   We also 
limited analyses to only those individuals who were still alive at least one year after their 
information was collected to minimize potential bias of poor health leading to decreased PA.  
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Nevertheless, our data does not account for differences in the severity of these conditions and 
may have contributed to the differences observed here.  Further, given the large age range of our 
cohort, we cannot exclude the possibility that differences in education, norms regarding 
behaviors or other unknown factors may have influenced the results here.  We have attempted to 
adjust for some of these factors by adjusting for education and ethnicity, but cannot ignore that 
there may be secular or cohort differences in how these factors influenced the associations 
observed in the present study.  Another limitation was that PA was only evaluated for the month 
prior to the survey interview, and lifetime PA patterns were not known. However, there is 
evidence to suggest that there is no modifying effect of past PA on the association between 
current activity and mortality risk in adults 
152
.  Still, we cannot preclude that individuals may 
have altered their PA patterns after our assessment.  However, these changes in PA patterns 
would likely result in an underestimation in the importance of PA observed in this study.     
In conclusion, across adulthood engaging in any number of moderate to vigorous PA 
bouts per week is associated with significantly lower mortality risk compared to being 
completely inactive. However, in adults 80 years and older, engaging in PA five or more 
times/week was associated with an even lower mortality risk.  Therefore, although PA may be 
beneficial for all ages, the association between PA frequency and mortality risk is strongest in 
very old adults.  Thus, in accordance with the previous PA guidelines, all adults, and in particular 
very old adults may benefit from participating in PA five or more times a week.   
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Table 3.1. Baseline characteristics of 9249 adults from the NHANES III (1988-1994) Survey 
stratified by physical activity level and age category.   
PA level Inactive Light Moderate Very Active 
     
Middle-aged     
Total (N=5311) 1119 (21) 1416 (27) 803 (15) 1973 (37) 
Age (y) 52.3 ± 7.6 51.2 ± 7.7 51.3 ± 7.7 51.7 ± 7.8* 
Males  420 (37) 671 (47) 404 (50) 1067 (54)* 
BMI (kg/m
2
) 28.9 ± 6.4 28.3 ± 5.8 27.9 ± 5.5 27.5 ± 5.3* 
Education      
< High school  625 (56) 585 (41) 244 (30) 580 (29)* 
High school  316 (28) 476 (34) 284 (35) 616 (31) 
> High school 177 (16) 355 (25) 275 (34) 777 (40)* 
White Ethnicity  305 (27) 576 (41) 405 (50) 952 (48)* 
Smoking Status      
Never 461 (41) 577 (41) 329 (41) 809 (41) 
Past 267 (24) 390 (28) 257 (32) 644 (33)* 
Current  390 (35) 449 (32) 271 (27) 520 (26)* 
CVD  529 (47) 582 (42) 302 (37) 740 (38)* 
T2D  172 (15) 201 (14) 96 (12) 189 (10)* 
Dyslipidaemia
 
 286 (26) 384 (27) 236 (29) 518 (26) 
Deaths  283 (25) 234 (17) 114 (14) 307 (16)* 
Self-rated health      
   Very Good/Exc  227 (20) 477 (34) 336 (42) 932 (47)* 
   Good 391 (35) 554 (39) 298 (37) 697 (35) 
   Fair/Poor 500 (45) 385 (27) 169 (21) 344 (17)* 
Mobility Impairment  169 (15) 87 (6) 45 (6) 82 (4)* 
     
Old     
Total (N=2719) 703 (26) 508 (19) 379 (14) 1129 (42) 
Age (y) 72.4 ± 4.3 71.4 ± 4.0 71.4 ± 4.0 71.4 ± 4.0* 
Males  256 (36) 265 (52) 182 (48) 629 (56)* 
BMI (kg/m
2
) 28.4 ± 6.8 27.8 ± 5.3 27.4 ± 4.5 26.7 ± 4.5* 
Education      
< High school  482 (69) 316 (62) 192 (51) 478 (42)* 
High school  140 (20) 115 (23) 107 (28) 307 (27) 
> High school  81 (12) 77 (15) 80 (21) 344 (30)* 
White Ethnicity 311 (44) 270 (53) 247 (65) 765 (68)* 
Smoking Status      
Never 309 (44) 233 (46) 174 (46) 486 (43) 
Past 269 (38) 171 (34) 155 (41) 504 (45) 
Current 125 (18) 104 (20) 50 (13) 139 (12) 
CVD  507 (72) 325 (64) 258 (68) 684 (61)* 
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T2D  200 (28) 105 (21) 59 (16) 178 (16)* 
Dyslipidaemia  196 (28) 165 (32) 112 (30) 335 (30) 
Deaths  511 (73) 305 (60) 208 (55) 6245 (55)* 
Self-rated health      
   Very Good/Exc 103 (15) 141 (28) 134 (35) 482 (43)* 
   Good 210 (30) 183 (36) 136 (36) 338 (34) 
   Fair/Poor 390 (55) 184 (36) 109 (29) 259 (23)* 
Mobility Impairment
 
 330 (47) 91 (18) 61 (16) 171 (15)* 
     
Very old      
Total (N=1219) 495 (41) 176 (14) 129 (11) 419 (34) 
Age (y) 84.7 ± 3.1† 83.7 ± 3.1† 83.6 ± 2.6† 83.9 ± 3.1*† 
Males  169 (34) 97 (55) 74 (57) 237 (56)* 
BMI (kg/m
2
) 25.1 ± 4.9† 25.5 ± 4.3† 25.3 ± 4.5† 24.8 ± 3.5*† 
Education      
< High school 316 (64) 102 (58) 64 (50) 231 (55)* 
High school  95 (19) 38 (22) 31 (24) 83 (20) 
> High school  83 (17) † 36 (20) † 34 (26) † 105 (25)* † 
White Ethnicity  391 (79) † 152 (86) † 110 (85) 364 (87) † 
Smoking Status     
Never 291 (59) † 93 (53) † 73 (57) † 248 (60) † 
Past 173 (35) † 73 (41) † 51 (39) † 148 (35) † 
Current 30 (6) † 10 (6) † 5 (4) † 23 (5) † 
CVD  366 (74) † 133 (76) † 95 (74) † 287 (69) † 
T2D  82 (17) † 23 (13) 20 (16) † 57 (14) † 
Dyslipidaemia
 
 106 (21) 35 (20) 26 (20) 83 (20)† 
Deaths  480 (97) † 164 (93) † 123 (95) † 384 (92)*† 
Self-rated health     
   Very Good/Exc 100 (20) 67 (38) 38 (29) † 165 (39)* † 
   Good 161 (33) 60 (34) † 49 (38) 133 (32) † 
   Fair/Poor 233 (47) 49 (28) 42 (33) † 121 (29)* † 
Mobility Impairment 340 (69) † 63 (36) † 38 (29) † 142 (34)* † 
 
* = significant trend across PA level within age group (P < 0.05).  † = significant trend across 
age within a PA group (P < 0.05).   BMI = body mass index; CVD = cardiovascular disease; Exc 
= excellent; PA = physical activity, T2D = type II diabetes.  Values are means ± SD or 
 
n (%).   
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Figure 3.1.  Hazard ratios for mortality risk in 9,249 adults from the NHANES III (1988-1994) 
survey stratified by age and physical activity level.  Group comparisons were made between all 
physical activity levels within each age group.  * = different from inactive within that age group 
(P < 0.05), † = different from lightly active within that age group (P < 0.05), ‡ = different from 
moderately active within that age group (P < 0.05).  PA = physical activity. 
  
* * * * * * 
† 
Middle-Aged 
40-64 y 
Old 
65-79 y 
Very Old 
80+ y 
= inactive 
= lightly active 
= moderately active  
 
 
 
* * 
‡ * 
= very active 
Ref Ref  
Figure 3.1 
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Abstract 
Aims: This study determined the joint association between PA, pharmacotherapy, and HbA1c 
control on all-cause and cardiovascular mortality risk in adults with and without T2D.  Methods:  
12,060 adults from NHANES III and NHANES continuous (1999-2002) surveys were used.  
Cox proportional hazards analyses were included to estimate mortality risk according to physical 
activity, pharmacotherapy, and glycemic control (HbA1c <7.0%) status, with physically active, 
treated and controlled (goal situation) as the referent.  Results:  Compared to the referent, adults 
with T2D who were uncontrolled, or controlled but physically inactive had a higher all-cause 
mortality risk (p < 0.05). Compared to the referent, only adults with T2D who were physically 
inactive had a higher CVD mortality risk, regardless of treatment or control status (p < 0.05).  
Normoglycemic adults had a similar all-cause and CVD mortality risk as the referent (p > 0.05).  
Conclusions:  Physical activity and glycemic control are both associated with lower all-cause 
and cardiovascular mortality risk in adults with T2D.  Adults with T2D who are physically 
active, pharmacologically treated, and obtain glycemic control may attain similar mortality risk 
as normoglycemic adults.     
 
Key Words: Leisure Activities; HbA1c; NHANES; Type 2 Diabetes Mellitus  
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Introduction  
Type 2 diabetes is an established risk factor for myocardial infarction, stroke, lower 
extremity amputation, blindness, kidney failure, and premature mortality 
88
.  Cardiovascular 
disease is a major complication of T2D and is the leading cause of death in this population 
88
.  
Type 2 diabetes affects 11.3% of the U.S. adult population, of which 84% are receiving 
antihyperglycemic therapy 
88
, with approximately half of adults and two thirds of older adults 
achieving glycemic control as defined as HbA1c <7.0% (53 mmol/mol) 
158
.  For the management 
of hyperglycemia, pharmacotherapy is recommended, as well as lifestyle modification, which 
includes participating in regular PA 
159
.  Physical activity has been reported to be associated with 
decreased baseline glycosylated hemoglobin (HbA1c) levels 
97
 and decreased mortality risk in 
individuals with T2D 
160
.  There is also substantial evidence that pharmacotherapy for T2D can 
significantly reduce HbA1c 
161
.  However, evidence regarding mortality outcomes of achieving a 
controlled HbA1c (<7.0% (53 mmol/mol), is equivocal, as some have reported lower mortality 
risk 
107,108
, no effect on mortality risk 
162
, as well as increased mortality risk 
110,163
.  There is also 
mixed evidence regarding if antihyperglycemic treatment lowers mortality risk to that of 
normoglycemic populations 
115–117
.   
  Although PA and pharmacological therapy are both recommended for T2D management, 
to our knowledge the joint association between PA, pharmacological treatment of T2D, and 
control of HbA1c with mortality risk has not been investigated.  Therefore, the objectives of this 
study were to determine the joint associations between PA, antihyperglycemic treatment, and 
glycemic control on all-cause, and CVD mortality risk.  
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Methods 
Participants 
Data was obtained from persons in the United States who participated in the NHANES III 
survey (1988-1994; n = 33 994), and NHANES Continuous surveys 1999-2000 (n = 9 965) and 
2001-2002 (n = 11 039).  A detailed explanation of the data collection methods has been 
previously reported 
145,146,164
.  Mortality information for NHANES III and NHANES Continuous 
survey participants was provided by the National Centre for Health Statistics using probabilistic 
record matching with death certificate data found in the National Death Index (NCHS Linked 
Mortality File) through December 31, 2006. All participants gave written informed consent prior 
to participation, and the methods were approved by the National Centre for Health Statistics.  
The total number of participants from all three surveys was 54 998.  Individuals were excluded if 
they were considered to have type 1 diabetes as defined as self-report diagnosis of diabetes 
before the age of 30 and taking insulin since diagnosis 
108
 (n=148), if they were younger than 40 
years (n = 36 910), or if they had missing information for HbA1c (n=22 287), or years since 
diagnosis for adults with T2D (n=1 562), leaving a final sample size of 12 060 men and women 
for this sample.       
Questionnaires and Physical Examination 
During the physical examination, height and weight were measured by a trained 
technician and BMI was calculated.  HbA1c was measured using blood samples via venipuncture 
and plasma glucose was measured after a 6-12 hour fast during the physical examination.  In 
NHANES III only, an oral glucose tolerance test was conducted in mobile center examinees over 
the age of 40 years.  Use of any prescription medications was reported during the household 
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interview and T2D drugs were identified.  Individuals reported if they had a doctor’s diagnosis of 
T2D, and the length of time since diagnosis.  
Physical activity in NHANES III was assessed as the monthly frequency of the following 
activities:  walking, jogging, biking, swimming, calisthenics, gardening, weight lifting, aerobics, 
and dancing.  Participants could also list up to four additional activities.  In the NHANES 
continuous surveys, respondents reported PA frequency in terms of the number of times per day, 
week, or month, as they preferred. Participants were asked about transportation, home or yard 
physical activity, or any other moderate or vigorous leisure time activity.  For the purpose of this 
analysis, monthly PA from all questionnaires was converted to weekly PA.  Since it has been 
shown that engaging in PA just once a week is beneficial for mortality risk 
19,20
, physically active 
was defined as participating in ≥1 time/week of physical activity, and physical inactivity was 
defined as participating in no weekly physical activity. 
Questionnaires were used to assess age, sex, education (less than high school, high 
school, more than high school), ethnicity (white or non-white), and smoking status (current, past, 
or never).  Individuals were considered hypertensive if they had self-reported doctor’s diagnosis 
of hypertension, if they were taking antihypertensive medications, if their systolic blood pressure 
was > 140 mmHg (> 130 mmHg if had T2D), or if their diastolic blood pressure was >90 mmHg 
(> 80 mmHg if had T2D).  Type 2 diabetes was defined as self-reported doctor’s diagnosis of 
T2D, or taking antihyperglycemic drugs, or having an HbA1c of > 6.5% (48 mmol/mol), or a 
fasting plasma glucose of > 7.0 mmol/L, or a 2-hour plasma glucose of > 11.0 mmol/L after an 
oral glucose tolerance test.  Individuals were considered dyslipidaemic if they were taking lipid 
medications, if their fasted cholesterol was > 6.2 mmol/L, or if their fasted triglycerides were > 
2.3 mmol/L.  History of CVD was defined as having a doctor’s diagnosis of coronary heart 
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disease, or prior diagnosis of a heart attack or stroke.  For the purpose of this analysis, acceptable 
glucose control was defined as an HbA1c <7.0 % (53 mmol/mol), while > 7.0 % (53 mmol/mol) 
was the criterion for uncontrolled glucose. Individuals were classified as either being treated or 
not being treated with antihyperglycemic drugs.  Death was categorized as all-cause, or CVD 
(ICD-10 codes 53-75). 
Statistical Analyses 
Group differences in subject characteristics were determined with one-way analysis of 
variance (ANOVA) and chi-square tests.  Cox proportional hazards were used to estimate 
differences in all-cause and CVD mortality risk, according to physical activity level, 
antihyperglycemic treatment and HbA1c control.  The proportional hazards assumption was 
verified for all models.  Adults with T2D who were physically active, treated and controlled 
(goal situation) was the referent group.  In a separate model hazard ratios stratified by glycemic 
control were adjusted for HbA1c to determine if baseline HbA1c differed between treatment and 
physical activity groups.  Multivariate analyses were adjusted for age, sex, education, ethnicity, 
and smoking status in the first model, and then additionally adjusted for dyslipidaemia, CVD, 
hypertension, BMI, and years since diagnosis in the final, fully adjusted models.  All statistical 
analyses were performed with SAS vs. 9.3 and results were considered statistically significant at 
p < 0.05.   
Results  
The average follow-up time was 9.2 ± 4.9 years, during which there were 3306 (27.4%) 
all-cause deaths, of which 45.6% were CVD related (n = 1509).  Subject characteristics 
according to PA status, glycemic control, and antihyperglycemic treatment are presented in 
Table 4.1. There were 1511 (12.5%) adults with T2D, wherein 46% participated in PA at least 
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once a week, 43% had glycemic control (HbA1c < 7.0%), and 71% were pharmacologically 
treated.  The average number of years since T2D diagnosis was 10.9 ± 8.8 years. Adults with 
T2D, who were physically active, treated and controlled, had a higher HbA1c and BMI, and a 
higher prevalence of hypertension and CVD than normoglycemic adults (p < 0.05).   All results 
were similar between the first multivariable model and the fully adjusted model for all-cause and 
CVD mortality, and thus only results for the fully adjusted models are reported.  There were no 
interaction effects between physical activity, antihyperglycemic treatment, or HbA1c control for 
all-cause or CVD mortality (p > 0.05 for all).   
There was a significant main effect of being physically active (all-cause HR, 95%CI= 
0.71, 0.66-0.76, p < 0.001; CVD 0.64, 0.58-0.72, p < 0.001), and having glycemic control (all-
cause 0.73, 0.63-0.86, p < 0.001; CVD 0.73, 0.58-0.93, p < 0.01) but not antihyperglycemic 
medication usage (all-cause 1.12, 0.96-1.31, p = 0.14; CVD 1.18, 0.94-1.47, p = 0.16).  
Adjustment for HbA1c within HbA1c control strata did not alter the significant effects of 
physical activity and antihyperglycemic treatment on all-cause or CVD mortality risk.   
The hazard ratios for all-cause (Figure 4.1) mortality risk are presented by PA, 
antihyperglycemic treatment, and HbA1c control.  Compared to adults with T2D who were 
physically active, treated and controlled (goal referent), adults with T2D who were uncontrolled, 
regardless of physical activity or treatment status, or controlled but physically inactive, had a 
higher all-cause mortality risk (p < 0.05).  Physically active, untreated and controlled adults with 
T2D, and normoglycemic adults, had a similar all-cause mortality risk as compared to the 
referent (p > 0.05) (Figure 4.1).   
The hazard ratios for CVD (Figure 4.2) mortality risk are presented by PA, 
antihyperglycemic treatment, and HbA1c control.  Compared to the referent, physically inactive 
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adults with T2D had a higher CVD mortality risk.  Conversely, physically active adults had a 
similar CVD mortality risk, regardless of treatment or control status (P>0.05).  Normoglycemic 
adults had a similar CVD mortality risk as the referent regardless of PA status (p > 0.05) (Figure 
4.2).  
Discussion  
To our knowledge this is the first study to determine the joint association between PA, 
pharmacotherapy, and glycemic control for all-cause and CVD mortality risk in adults with and 
without T2D.  The importance of PA was particularly evident for CVD mortality risk as adults 
with T2D who were physically inactive, regardless of treatment or control status, had a higher 
mortality risk compared to adults with T2D who were active, treated and controlled.  
Interestingly, the goal situation for T2D of being physically active, being pharmacologically 
treated, and having glycemic control had a similar mortality risk as normoglycemic adults.  
Altogether these results demonstrate the potential importance of PA and glycemic control in 
populations with T2D.       
 Several studies have shown an inverse association between PA and mortality risk in 
populations with T2D 
99,160
.  To our knowledge we are the first to assess this association in 
conjunction with treatment and glycemic control, and demonstrate that PA is independently 
associated with lower all-cause and CVD mortality risk.  This occurred despite defining 
physically active as participating in any moderate or vigorous physical activity a week.  
However, several studies have shown that any amount of PA is associated with lower mortality 
risk compared to being physically inactive 
19,20
, including in adults with T2D 
100,101
.  The 
beneficial health effects of PA may be attributed to, but are not limited to, improved antioxidant 
and anti-inflammatory status 
165
, reduced hyperglycemica 
166
, increased exercise capacity and 
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muscle strength, as well as improved baroreflex sensitivity 
167
.  Physical activity is well known 
to improve CVD risk factors 
123
 as well as reduce risk of CVD and CVD related death in 
populations with T2D 
101
. Our results further support the evidence of the benefits of PA for 
persons with T2D independent of pharmacological treatment, or glycemic control.  Although 
there are clear benefits of physical activity for managing T2D, in the present study fewer adults 
with T2D were physically active compared to adults without T2D (46 vs 59%).  Given the strong 
inverse association between PA and mortality risk, our results reinforce the positive benefits of 
participating in PA, particularly for adults with T2D. 
Achieving glycemic control (HbA1c < 7.0% (53 mmol/mol)) is often the goal for T2D 
management as there is evidence that controlled T2D is associated with lower mortality risk and 
macrovascular and microvascular complications 
107,168
. A recent investigation reported that 
independent of PA, uncontrolled HbA1c was associated with increased mortality risk compared 
to controlled HbA1c 
169
.  We further these observations in demonstrating that in adults with T2D, 
poor glycemic control, irrespective of PA or treatment status, was associated with higher all-
cause mortality risk compared to those who were active, treated, and controlled.   However, even 
when glycemic control was achieved, those who were physically inactive still had a higher all-
cause mortality risk compared to active adults who were treated and controlled.  Additionally, 
active adults with controlled T2D did not differ in mortality risk with treatment status.  The 
individuals with controlled glycemic status, who reported a doctor’s diagnosis of diabetes but no 
pharmacological treatment, were likely managing their diabetes through lifestyle management 
only 
170
.  Persons with T2D who were managing their disease with lifestyle only were reported to 
have had lower HbA1c compared to persons who were receiving pharmacological treatment 
158
, 
which is consistent with the results for glycemic control in the present study.  Thus, in adults 
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with T2D, it appears that both being physically active and obtaining glycemic control is 
beneficial for mortality risk.   
For adults living with T2D, being physically active is important, and many may require 
pharmacological treatment to attain glycemic control as most cannot achieve this with lifestyle 
alone.  Indeed, individuals with T2D who were physically active, treated and controlled had a 
similar all-cause and CVD mortality risk compared to adults without T2D.  Although other 
studies have reported an increased risk in all-cause 
115,116
 and CVD mortality 
171
 in adults with 
T2D, these studies did not specifically compare subgroups of individuals who differed in PA, 
pharmacological treatment, and glycemic control status.  It was recently reported that adults with 
T2D who participate in as little as 1-2 hours a week of light PA achieve similar mortality risk as 
normoglyecmic adults 
106
.We extend these observations by showing that the subgroup of adults 
with T2D who were physically active, pharmacologically treated, and controlled had a similar 
mortality risk as normoglycemic adults.  These results are encouraging given that they indicate 
that lifestyle modification and pharmacological treatment of diabetes may successfully lower 
mortality risk to that of normoglycemic populations.  However, due to the observational design 
of this study, we cannot imply causation, and further research would be needed to confirm these 
findings.    
 The major strength of this study was the use of large samples of U.S. adults from the 
population-based NHANES surveys.  As NHANES collects data on many health and lifestyle 
parameters, we were also able to show the independent associations of physical activity, as well 
as treatment and control of T2D, after adjusting for numerous health-related risk factors.  
Limitations of this study also warrant mention. The current study used prospective observational 
data and therefore no causation can be implied.  Development of T2D, or any change, start or 
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discontinuation of medications after baseline is not known.  All PA was self-reported, and 
lifetime PA patterns were not known.  However, Bembom et al., (2009) reported that the 
association between PA level assessed at the time of the study and mortality risk is not modified 
by previous or lifetime physical activity levels 
152
. We were also unable to apply sample weights 
to the analysis due to the combined use of NHANES III and continuous surveys.  Thus, our 
results are not necessarily reflective of the U.S. population, but make our analysis no less 
internally valid.  As well, we did not have a large enough sample size to examine if there were 
any differences in mortality risk between individuals on different classes of T2D medications. 
In conclusion, both PA and glycemic control appear to be associated with lower all-cause 
and CVD mortality risk in adults with T2D.  Since individuals with T2D tend to be less 
physically active than the general population, targeted efforts may be needed to increase PA 
among adults with T2D.  In adults with T2D, PA, pharmacological treatment, and glycemic 
control was associated with a similar mortality risk as adults without T2D. 
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Table 4.1.  Baseline characteristics of 12 060 adults from the NHANES III, and NHANES Continuous (1999-2000, 2001-2002) 
surveys. 
 Controlled T2D Uncontrolled T2D Normoglycemic 
 Treated Untreated Treated Untreated 
 Physically 
Active 
Physically 
Inactive 
Physically 
Active  
Physically 
Inactive 
Physically 
Active 
Physically 
Inactive 
Physically 
Active 
Physically 
Inactive 
Physically 
Active 
Physically 
Inactive 
Total  190 (1.6) 191 (1.6) 116 (1.0) 153 (1.3) 326 (2.7) 373 (3.1) 65 (0.5) 97 (0.8) 6230 (51.7) 4319 (35.8) 
Age (years) 66.5 ± 11.3 69.1 ± 11.2 65.5 ± 12.5 67.5 ± 12.1 63.5 ± 
11.1* 
64.9 ± 11.6 63.0 ± 11.6 64.1 ± 11.5 59.5 ± 
13.7* 
62.0 ± 
14.6* 
Men  43.7 43.5 51.7* 37.9* 55.2* 41.0 60.0* 38.1* 52.2* 41.4 
White  39.5 35.6 40.5 35.3 38.7 31.1 44.6 23.7* 41.0 36.9 
Education           
< high 
school 
79.0 82.7 70.7* 78.4 72.4 86.1* 73.8 84.5 63.9* 75.6 
High school 13.7 10.5 13.8 13.1 16.3 8.6* 10.8 7.2* 16.8 14.8 
> high 
school 
7.4 6.8 15.5* 8.5 11.4 5.4 15.4* 8.3 19.3* 9.6 
Smoking           
Never 44.8 46.6 44.8 47.7 48.5 50.1 38.5 54.6* 45.7 47.9 
Past 45.3 41.9 37.1 33.3* 42.0 33.5* 41.5 29.9* 36.3 28.2* 
Current  10.0 11.5 18.1* 19.0* 9.5 16.4 20.0* 15.5 18.0* 23.9* 
HbA1c  6.2 ± 0.5 6.1 ± 0.5 5.9 ± 0.6* 5.9 ± 0.6* 8.9 ± 1.8* 9.1 ± 1.7* 9.0 ± 1.8* 8.9 ± 2.0* 5.4 ± 0.4* 5.4 ± 0.4* 
HBP  82.6 89.0 75.9 82.4 79.5 79.1 75.4 80.4 47.4* 54.2* 
CVD  23.7 36.1* 24.1 28.1* 19.6 25.5 15.4 29.9* 9.7* 12.9* 
DYSLIPID 39.5 41.9 42.2 33.3 45.7 39.7 47.7 37.1 34.5 32.8 
BMI 
(kg/m²) 
29.4 ± 4.9 29.8 ± 5.4 28.4 ± 4.6 28.7 ± 5.1 30.3 ± 6.0* 29.6 ± 5.0 28.3 ± 3.8 29.6 ± 5.2 27.5 ± 4.5* 28.0 ± 5.2* 
Years since 
diagnosis  
9.5 ± 8.9 10.4 ± 8.9* 9.0 ± 8.3 12.1 ± 9.5* 11.3 ± 8.1* 11.8 ± 8.9* 11.3 ± 9.7* 9.9 ± 8.4 NA NA 
Drug 
classes 
          
SU 136 (71.6) 127 (66.5) NA NA 204 (62.6)* 221 (59.3)* NA NA NA NA 
TZD 11 (5.8) 10 (5.2) NA NA 29 (8.9) 20 (5.4) NA NA NA NA 
Insulin 31 (16.3) 47 (24.6)* NA NA 108 (33.1)* 146 (39.1)* NA NA NA NA 
Biguanide 47 (24.7) 37 (19.4) NA NA 69 (21.2) 61 (16.4)* NA NA NA NA 
Deaths           
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* = significantly different from physically active, treated and controlled (Goal type 2 diabetes condition) (p < 0.05).  BMI = body mass 
index; CVD = cardiovascular disease; HBP = high blood pressure; DYSLIPID = dyslipidemia; SU = sulphonylurea; TZD = 
thiazolidinedione.  Values are means ± SD, N (%), or %.  Note: row 1 is row %, all else are column %.    
 
All-cause  68 (35.8) 85 (44.5) 52 (44.8) 81 (52.9) 132 (40.5) 166 (44.5) 30 (46.2) 45 (46.4) 1301 (20.9) 1346 (31.2) 
CVD  30 (15.8) 40 (20.9) 22 (19.0) 42 (27.4) 57 (17.5) 80 (21.5) 12 (18.5) 20 (20.6) 567 (9.1) 639 (14.8) 
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Figure 4.1.  Hazard ratios and 95% confidence intervals for all-cause mortality risk according to 
physical activity level, antihyperglycemic treatment status and HbA1c control status. The model 
was adjusted for age, sex, education, ethnicity, smoking status, cardiovascular disease, 
hypertension, dyslipidemia, body mass index, and years since T2D diagnosis.  HR = hazard ratio. 
  
 Figure 4.1 
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Figure 4.2.  Hazard ratios and 95% confidence intervals for cardiovascular disease mortality risk 
according to physical activity level, antihyperglycemic treatment status, and HbA1c control 
status. The model was adjusted for age, sex, education, ethnicity, smoking status, cardiovascular 
disease, hypertension, dyslipidemia, body mass index, and years since T2D diagnosis.  HR = 
hazard ratio.  
  
Figure 4.2 
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Abstract 
Background: The purpose of this study was to determine the joint association between PA, 
pharmacological treatment, and control of blood pressure on all-cause mortality risk.  Methods: 
10 665 adults from NHANES III and NHANES continuous (1999-2000 and 2000-2001) surveys 
were used.  Cox proportional hazards analyses were used to estimate differences in mortality risk 
by PA, pharmacological treatment, and blood pressure control, with physically active, treated 
and controlled as the referent.  Results: The average follow-up time was 8.6 ± 4.8 years.  The 
main effect of PA was significant independent of pharmacological treatment and blood pressure 
control (p<0.001).  Compared to physically active adults with treated and controlled 
hypertension, physically inactive adults with hypertension had a higher mortality risk (inactive, 
treated and controlled hypertension: HR 1.42, 95% CI 1.17-1.72, p<0.01; inactive, treated and 
uncontrolled hypertension: 1.55, 1.30-1.84, p<0.01; inactive, untreated, and uncontrolled 
hypertension: 1.27, 1.07-1.52, p<0.01), whereas physically active adults with hypertension did 
not significantly differ in mortality risk (active, treated and uncontrolled hypertension: 1.17, 
0.98-1.40, p=0.08; active, untreated and uncontrolled hypertension: 0.90, 0.76-1.08, p=0.25).  
Physically active, normotensive individuals had a lower mortality risk compared to the referent 
(0.72, 0.60-0.86, p<0.01), whereas physically inactive, normotensive individuals had a similar 
mortality risk as the referent (1.08, 0.90-1.30, p=0.42).  Conclusions: Physical activity may be as 
or even more important than pharmacotherapy for mortality risk in adults with hypertension. 
However, mortality risk remained higher than physically active normotensive populations. Thus, 
prevention of hypertension is imperative for reduction of premature mortality risk.   
Key Words: Leisure Activities; Blood Pressure; Hypertension; NHANES; Mortality; 
Anithypertensive Agent  
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Introduction  
 
Hypertension is an established risk factor for myocardial infarction, stroke, and 
premature mortality 
89
.  Hypertension affects approximately 30% of U.S. adults, of which 81% 
are aware of their condition, 76% are treated with antihypertensive medications, and only 53% of 
individuals with hypertension obtain blood pressure control targets of <140/90 mmHg 
119
.  For 
the management of hypertension, pharmacotherapy is recommended, as well as lifestyle 
modification, which includes participation in regular physical activity 
120,159
.  Physical activity 
has been shown to reduce blood pressure 
122 
and mortality risk 
143
 in hypertensive populations.  
There is also substantial evidence that pharmacotherapy for hypertension can significantly 
reduce resting blood pressure 
172
.  Achieving blood pressure control (<140/90 mmHg) has been 
associated with improved survival among hypertensive patients 
136–138
, yet some studies report 
that blood pressure control has no effect on mortality risk 
139,140
.
 
 It is also unclear whether 
antihypertensive treatment lowers mortality risk to that of normotensive populations, with studies 
showing mixed results 
136,173
.   
  Although PA and pharmacological therapy are both recommended for hypertension 
management, to our knowledge the joint association between PA, pharmacological treatment of 
hypertension, and control of blood pressure with mortality risk has not been investigated.  
Therefore, the objectives of the study were to determine the joint associations between PA, 
antihypertensive treatment, and blood pressure control on mortality risk. 
Methods 
Participants 
Data were obtained from persons in the United States who participated in the NHANES 
III survey (1988-1994; n = 33 994), and NHANES Continuous surveys 1999-2000 (n = 9965) 
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and 2001-2002 (n = 11039).  A detailed explanation of the data collection methods has been 
previously reported 
145,146,164
.
 
 Mortality information for NHANES III and NHANES Continuous 
survey participants was provided by the National Centre for Health Statistics using probabilistic 
record matching with death certificate data found in the National Death Index (NCHS Linked 
Mortality File) through December 31, 2006. All participants gave written informed consent prior 
to participation, and the methods were approved by the National Centre for Health Statistics.  
The total number of participants from all three surveys was 54 998.  Individuals were excluded if 
they were younger than 40 years, or if they had missing information for PA, systolic or diastolic 
blood pressure, or hypertension medications, leaving a final sample size of 10 665 men and 
women.     
Questionnaires and Physical Examination 
Blood pressure was measured with a mercury sphygmomanometer according to the 
standardized blood pressure measurement protocols by the American Heart Association.
(17) 
 
Blood pressure was determined as the average of six readings; three sets of measurements were 
taken by interviewers during the household questionnaire visit, and again by a physician during 
the physical examination.  Use of any prescription medications was reported during the 
household interview and the names of the drugs were recorded.  A pharmacist reviewed all 
reported medications and coded them into therapeutic classes (i.e. hypertension) for all three 
NHANES surveys.   
Physical activity in NHANES III was assessed with a questionnaire that inquired about 
monthly frequency of the following activities:  walking, jogging, biking, swimming, calisthenics, 
gardening, weight lifting, aerobics, dancing, and up to four additional activities.  Each activity 
was assigned a metabolic equivalent score (MET) using a standardized coding scheme 
174
 and 
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only activities that were at least a moderate intensity (MET ≥ 3) were included in the analysis.  
In the NHANES continuous surveys, respondents answered questions about PA in terms of 
number of times per day, week, or month, as they preferred. The data were standardized to 
monthly frequency.  Participants were asked about walking or biking as transportation to work, 
school or to run errands, if they had performed home or yard work that lasted at least 10 minutes 
and was at a moderate or vigorous effort, and if they had engaged in any moderate or vigorous 
leisure time activity.  For the purpose of this analysis, monthly PA from all questionnaires was 
converted to weekly PA and only activities that were at least a moderate intensity 
174
 were 
included in the analysis.  Since it has been shown that engaging in PA just once a week is 
beneficial for mortality risk 
19,20
, physically active was defined as participating in ≥1 time/week 
of PA, and physical inactivity was defined as participating in no weekly PA. 
Questionnaires were used to assess age, sex, education (less than high school, high 
school, more than high school), ethnicity (white or non-white), and smoking status (current, past, 
or never).  Self-reported height and weight were used to calculate BMI.  Individuals were 
considered hypertensive if they had self-reported doctor’s diagnosis of hypertension, if they were 
taking antihypertensive medications, or if their systolic blood pressure was > 140 mmHg or if 
their diastolic blood pressure was >90 mmHg.  T2D was defined as self-reported doctor’s 
diagnosis of T2D, or taking antihyperglycemic drugs.  Individuals were considered 
dyslipidaemic if they were taking lipid medications, if their fasted cholesterol was > 6.2 mmol/L, 
or if their fasted triglycerides were > 2.3 mmol/L.  Presence of cardiovascular disease (CVD) 
was defined as having a doctor’s diagnosis of coronary heart disease, or prior diagnosis of a heart 
attack or stroke.  For the purpose of this analysis, uncontrolled blood pressure was defined as a 
systolic blood pressure > 140 mmHg (> 130 mmHg for individuals with T2D), or a diastolic 
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blood pressure of > 90 mmHg (> 80 mmHg for individuals with T2D).  Controlled blood 
pressure was defined as having a blood pressure of <140/90 mmHg, (<130/80 mmHg for 
individuals with T2D).  Individuals were classified as either being treated or not being treated 
with antihypertensive drugs.   
Statistical Analyses 
Group differences in subject characteristics were determined with one-way analysis of 
variance (ANOVA) and chi-square tests.  Kaplan Meier survival curves stratified by treatment, 
control and physical activity were used to assess unadjusted survival times. Cox proportional 
hazards analyses were used to assess differences in all-cause mortality risk by PA level, 
antihypertensive treatment, and blood pressure control.  Adults with hypertension who were 
physically active, treated with antihypertensive medication, and had controlled blood pressure 
were the referent group (goal for hypertension).  To minimize potential bias of poor health 
leading to decreased PA, an identical model was conducted excluding individuals who died 
within the first year after they were examined. In a separate model, hazard ratios stratified by 
blood pressure control were adjusted for systolic and diastolic blood pressure to account for 
differences in blood pressure between treatment and PA groups. Multivariate analyses were 
performed to adjust hazard ratios for age, sex, education, ethnicity, smoking status, T2D, 
dyslipidaemia, CVD, and BMI.   All statistical analyses were performed with SAS vs. 9.3 and 
results were considered statistically significant at p < 0.05.   
Results  
The average follow-up time was 8.6 ± 4.8 years, with 2832 deaths (25.8%).  Subject 
characteristics by PA, blood pressure control, and antihypertensive treatment are presented in 
Table 5.1. Physically active individuals with treated and controlled hypertension (goal situation) 
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had a lower prevalence of T2D compared to all other hypertensive groups.  However, they had a 
higher systolic blood pressure and prevalence of T2D compared to normotensive adults (p < 
0.001).    
Unadjusted survival curves stratified by PA, treatment, and control are presented in 
Figure 5.1.  Log-rank tests were significantly different between active and inactive within each 
treatment and blood pressure control group, between treated and untreated within each blood 
pressure control and physical activity group, and between controlled and uncontrolled within 
each PA and treated group (p < 0.05, Figure 5.1).     
Hazard ratios for all-cause mortality risk by PA, antihypertensive treatment, and blood 
pressure control are shown in Figure 5.2.  There were no interactions between PA, 
antihypertensive treatment, or blood pressure control (p > 0.05).  Being physically active (HR, 
95%CI=0.71, 0.66-0.78, p < 0.001) and having controlled blood pressure (HR = 0.84, 0.78-0.92, 
p = 0.004) were both independently associated with lower mortality risk, whereas being treated 
with antihypertensive medication was independently associated with higher mortality risk (HR = 
1.29, 1.18-1.40, p < 0.001) (Figure 5.2).   Adjustment for systolic and diastolic blood pressure 
within blood pressure control groups did not alter the significant association of PA or 
antihypertensive treatment on mortality risk.  Compared to adults with hypertension who were 
physically active, treated and controlled, adults who had hypertension and were physically 
inactive, regardless of treatment or control status, had a higher mortality risk (p < 0.05 for all).  
Adults with hypertension who were physically active had a similar mortality risk regardless if 
blood pressure was controlled, or if treated with antihypertensive drugs (p > 0.05 for all).  
Compared to hypertensive adults who were active, treated and controlled, normotensive adults 
who were physically active had a lower mortality risk (HR = 0.72, 0.60-0.86, p < 0.001), 
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whereas normotensive inactive adults had a similar mortality risk (HR = 1.08, 0.90-1.30) (p = 
0.42) (Figure 5.2).  Exclusion of individuals who died within the first year of being examined 
did not change the significance of any of the results.   
Discussion  
 To our knowledge this is the first study to determine the joint association between PA, 
pharmacotherapy, and control of hypertension.  Based on this large-scale analysis of the 
NHANES data, we demonstrate that PA is independently associated with a dramatically lower 
mortality risk for adults with hypertension, regardless of pharmacological treatment and control 
status.  Moreover, our finding that adults with hypertension who were able to attain the goal 
situation (i.e. active, treated, and controlled blood pressure) had a similar mortality risk as 
normotensive adults who were inactive, demonstrates the value of PA, and attainment of goal 
blood pressure in this patient population.   However, it is still worth noting that those with 
hypertension who were able to attain the goal situation still had higher mortality risk compared 
to those without hypertension who were physically active.  Altogether these results demonstrate 
that PA and controlled blood pressure are important independent factors for the prevention of 
premature mortality risk.       
Several studies have shown an inverse association between PA and mortality risk in 
populations with hypertension 
143,175
.  To our knowledge the present study is the first to assess 
this association in conjunction with treatment and control of hypertension, and to show that PA is 
associated with decreased mortality risk independent of these two factors.  One study reported 
that hypertensive adults who were physically active had a reduced CVD mortality risk, compared 
to those who were hypertensive and physically inactive 
175
.
 
 Additionally, in a cohort of 
hypertensive men, increased exercise capacity was associated with lower mortality risk 
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independent of BMI 
176
.
  
The present study extends these findings by showing that among 
hypertensive adults, PA is associated with reduced mortality risk even if hypertensive individuals 
are not treated with pharmacotherapy and/or do not obtain controlled blood pressure, compared 
to those who are physically inactive.  Therefore, in adults with hypertension, PA may be critical 
for lowering premature mortality, especially for those who are treated but do not achieve blood 
pressure control. This is striking considering that our definition of active was participating in one 
or more bouts of moderate or vigorous PA a week.  However, numerous epidemiological studies 
have shown that the greatest gains from engaging in PA arise from transitioning from inactive to 
at least once per week 
19,20
.  There are several possible reasons why PA is beneficial for adults 
with hypertension. These include, but are not limited to, increased exercise capacity and muscle 
strength, reduced adiposity and inflammation, reduced blood pressure, enhanced endothelial 
function, improved baroreflex sensitivity, improved mental health and the regression of left 
ventricular hypertrophy 
123
.  Although there are clear benefits of PA for managing hypertension, 
in this study, only 53% of hypertensive adults participated in PA compared to 62% of 
normotensive adults.  Given the strong inverse association between PA and mortality risk, our 
results reinforce the benefits of PA, particularly for adults with hypertension.  
 For adults living with hypertension, being physically active, treated, and controlled would 
be the most ideal condition.  However, these individuals still had a higher mortality risk 
compared to physically active adults without hypertension.  Our results are in line with several 
other studies that have reported that treated and controlled hypertensive adults have a higher 
mortality risk compared to adults without hypertension 
140,173
.  In contrast, Gu et al., (2008) 
reported that hypertensive adults who were treated and controlled did not have a greater 
mortality risk compared to normotensive adults.  These discrepant results may be in part due to 
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the failure to consider for differences in PA.   Active, hypertensive adults who are treated and 
controlled may still have a higher mortality risk than normotensive physically active adults due 
to irreversable target organ damage prior to attaining treatment or achieving control 
177
 even with 
intensive therapy 
178
.
  
Indeed, 20% of U.S. adults with hypertension are undiagnosed 
89
.
 
 Another 
explanation is that individuals with disease may have had other co-morbidities or lifestyle factors 
that increased mortality risk.  Although, we did adjust for comorbidity and lifestyle risk factors 
(education, ethnicity, CVD, T2D, dyslipidaemia, BMI, and smoking) this may not have fully 
captured the severity of health differences between our groups.  Nevertheless, observations from 
this analysis suggest that medications and lifestyle modification do not sufficiently normalize 
mortality risk to physically active non-diseased conditions, highlighting the importance of 
disease prevention.  It is important to note that although antihypertensive treatment was 
independently associated with a higher mortality risk, this may be because individuals who were 
being treated were more likely to be sicker than participants who were not treated.  From the 
current data we cannot conclude that hypertension should not be pharmacologically treated.   
The major strength of this study was the use of large samples of U.S. adults from the 
population-based NHANES surveys.  As NHANES collects data on many health and lifestyle 
parameters, we were also able to show the independent associations of PA, pharmacological 
treatment, and blood pressure control of hypertension after adjusting for numerous health-related 
risk factors.  Limitations of this study also warrant mention. The current study used prospective 
observational data and therefore no causation can be implied.  Development of hypertension or 
any other co-morbidity, or change in medication usage after baseline is not known.  Further, due 
to limited sample sizes, we cannot preclude that certain hypertensive medications have 
differential effects on mortality risk.  Physical activity was self-reported, and lifetime PA 
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patterns were not known.  We were also unable to apply sample weights to the analysis due to 
the combined use of NHANES III and continuous surveys.  Thus, our results are not necessarily 
reflective of the U.S. population, but make our analysis no less internally valid. 
In conclusion, this study demonstrates that PA is associated with lower mortality risk in 
adults with hypertension, regardless of treatment or control status.  Thus, PA may be a very 
important aspect of managing hypertension.  Since mortality risk of adults with hypertension in 
even the most ideal condition (treated, controlled, and physically active), remained higher than 
that of physically active normotensive populations, it is imperative that efforts are made to 
prevent development of hypertension.   
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Table 5.1.  Baseline characteristics of 10,665 adults from the NHANES III and NHANES Continuous (1999-2000, 2001-2002) 
surveys. 
 
 
 Treated and Controlled Treated and 
Uncontrolled 
Untreated and 
Uncontrolled 
Normotensive 
 Active Inactive Active Inactive Active Inactive Active Inactive 
N  820 (7.7) 664 (6.2) 898 (8.4) 915 (8.6) 1304 (12.2) 1106 (10.4) 3022 (28.4) 1926 (18.1) 
Age (years) 64.7 ± 12.0 67.4 ± 12.2* 69.1 ± 11.6* 70.2 ± 11.5* 64.6 ± 13.0 65.8 ±13.7* 54.8 ± 11.9* 55.7 ± 12.5* 
Men (%) 52.8 42.6* 46.0* 32.2* 56.7* 46.8* 53.3 43.3* 
Education (%)          
< High school 76.0 82.5* 76.7 83.0* 72.6* 84.3* 66.9* 78.2 
High school 12.0 10.5 11.9 9.7 14.3 9.9 14.1 12.6 
> High school 12.0 7.0* 11.4 7.3* 13.1 5.7* 19.0* 9.2 
Ethnicity 
(%white) 
31.6 30.6 35.0 32.1 38.0* 33.4 37.4* 34.4 
Smoking (%)         
Never  40.4 45.2* 51.0* 51.2* 47.0* 47.4* 46.0* 44.5* 
Past 47.8 39.2* 40.1* 34.3* 38.3* 29.4* 33.0* 27.7* 
Current  11.8 15.6* 8.9 14.5* 14.7* 23.2* 21.0* 27.8* 
PA bouts/week 6.1 ± 4.1 0* 6.5 ± 4.3 0* 6.4 ± 4.2 0* 6.3 ± 4.3 0* 
SBP (mmHg) 123.7 ± 11.0 124.0 ± 10.9 156.8 ± 
16.0* 
158.7 ± 
17.5* 
154.2 ± 
16.0* 
157.5 ± 
17.6* 
119.9 ± 
11.0* 
120.5 ± 11.0* 
DBP (mmHg) 71.0 ± 9.8 69.0 ± 10.2 78.1 ± 12.8* 77.4 ± 13.8* 81.8 ± 12.6* 80.9 ± 12.6* 73.0 ± 8.0* 72.5 ± 8.4* 
T2D (%) 9.3 16.0* 28.8* 32.6* 16.0* 22.6* 3.8* 6.2* 
CVD (%) 26.8 30.2* 25.1 30.5* 7.6* 10.9* 4.5* 5.5* 
Dyslipidemia 
(%) 
34.5 31.0 32.9 27.8* 20.3* 17.2* 16.4* 14.6* 
BMI  (kg/m²) 28.5 ± 5.5 28.9 ± 6.2* 27.7 ± 5.3* 28.7 ± 6.5 27.1 ± 5.1* 27.3 ± 5.8* 26.6 ± 4.7* 27.4 ± 5.5* 
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* = significantly different from physically active, treated and controlled hypertension (p < 0.05).  BMI = body mass index; CVD = 
cardiovascular disease; DBP = diastolic blood pressure; T2D = type 2 diabetes; SBP = systolic blood pressure.   
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Figure 5.1.  Unadjusted survival curves by antihypertensive treatment, blood pressure control, and physical activity.  A = 
normotensive, active; B = normotensive, inactive; C = active, treated, controlled hypertensive; D = active, untreated, uncontrolled 
hypertensive; E = inactive, treated, controlled hypertensive; F = inactive, untreated, uncontrolled hypertensive; G = active, treated, 
uncontrolled hypertensive; H = inactive, treated, uncontrolled hypertensive.  * = significantly different from physically active within 
treatment - control groups (p < 0.05).  † = significantly different from treated within control - physical activity groups (p < 0.05). ‡ = 
significantly different from controlled within treated - physical activity groups (p < 0.05). 
 
 
Figure 5.1 
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Figure 5.2.  Mortality risk by physical activity level, antihypertensive treatment status and blood pressure control status.  The model 
was adjusted for age, sex, education, ethnicity,smoking status, cardiovascular disease, type II diabetes mellitus, dyslipidemia and body 
mass index.  * = significantly different mortality risk compared to active, treated, and controlled hypertensive adults p < 0.05).   
Figure 5.2 
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Abstract  
Introduction:  Knowledge of calories is important for weight management, yet few studies have 
investigated whether individuals can accurately estimate calories during exercise and in food.  
The objective of this study was to determine if accuracy of estimation of moderate or vigorous 
exercise energy expenditure and calories in food is associated with body weight class or weight 
loss status.  Methods:  Fifty-eight adults who were either normal weight (NW) or overweight 
(OW), and either attempting (WL) or not attempting weight loss (noWL), exercised on a 
treadmill for 25 minutes. Subsequently, participants estimated the number of calories they 
expended through exercise, and created a meal that they believed to be calorically equivalent to 
the exercise energy expenditure. Results: The mean difference between estimated and measured 
calories in exercise and food did not differ within or between groups following moderate 
exercise.  Following vigorous exercise, OW-noWL overestimated energy expenditure by 72%, 
and overestimated the calories in their food by 37% (P<0.05). OW-noWL also significantly 
overestimated exercise energy expenditure compared to all other groups (P<0.05), and 
significantly overestimated calories in food compared to both WL groups (P<0.05).  However, 
among all groups there was a considerable range of over and underestimation (-280 kcal to +702 
kcal), as reflected by the large and statistically significant absolute error in calorie estimation of 
exercise and food.   Conclusion:  The overall poor ability to estimate calories during exercise 
and in food, especially for overweight adults not attempting weight loss, may be a potential 
contributor to the generally poor weight loss success observed when attempted through diet and 
exercise.   
Key Words: body mass index; weight loss; energy expenditure; energy intake; exercise intensity  
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Introduction  
  Approximately 50% of adults in the United States are attempting to control their weight, 
with the most common methods including exercise and caloric restriction 
67
.  Weight loss occurs 
when energy intake is less than energy expenditure 
68
. Therefore, to successfully manage body 
weight, it would be beneficial for an individual to be able to accurately estimate the number of 
calories expended through exercise and consumed in a meal 
6
.  Previous research has 
demonstrated that adults generally underestimate calories in meals 
179,180
, and the few studies that 
have investigated how accurately adults estimate exercise energy expenditure have reported 
mixed findings 
76,81,82
.  Further, whether or not calorie estimation differs by weight class and 
weight loss status is not clear.  For example, while both dieters and non-dieters underestimated 
calories in a post-exercise meal 
75
, dieters have been reported to be more accurate at calorie 
estimation compared to non-dieters 
74
.  Additionally,  some studies have demonstrated that 
obesity is associated with poorer calorie estimation 
79,80
.  However, no study has simultaneously 
examined the effect of body weight class and weight loss status on calorie estimation accuracy. 
Furthermore, although knowledge of calories is reported to be important for weight management 
73
, whether or not calorie estimation ability is associated with better weight management has not 
been tested.    
  To date, only two studies have attempted to simultaneously determine how accurately 
adults estimate exercise energy expenditure and calories in food 
81,82
.  However, neither study 
examined participants with overweight or obesity, or the effects of weight loss status on caloric 
estimates.  Further, only one study has examined the impact of exercise intensity on the accuracy 
of calorie estimation 
82
.  Given the importance of calorie estimation for weight management, the 
present study aimed to determine if accuracy of estimation of moderate or vigorous exercise 
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energy expenditure and calories in food is influenced by body weight class and intention to lose 
weight.   
 
Methods 
Participants 
 Adults between the ages of 18-65 years were recruited via poster advertisement from a large 
urban university setting.  Participants were screened for eligibility as assessed by a Physical Activity 
Readiness Questionnaire (PAR-Q) form.  Participants were assessed over three visits that were at the 
same time of day approximately one week apart.  Participants were instructed to refrain from exercising 
at least 24 hours prior, and to avoid eating, smoking, or drinking caffeinated beverages for a minimum 
of two hours prior to each experimental session.  Informed written consent was obtained prior to 
participation.  The procedures for this study have been approved by the local university ethics board and 
conform to the Declaration of Helsinki.    
Procedures and Protocol 
Participants were categorized into 1 of 4 groups based on weight and weight loss status: normal 
weight (NW) (BMI ≥18 and <25 kg/m²), or overweight/obese (OW) (BMI ≥ 25 kg/m²), and either 
attempting (WL) or not attempting weight loss (noWL).  During the first session, participants completed 
a variety of demographic, health, and lifestyle related questionnaires, including a question that inquired 
whether or not participants were currently attempting weight loss.  To determine BMI, height was 
measured by a stadiometer (Seca Telescopic Height Rod, Model 220, Hamburg, Germany), and weight 
was measured with a mechanical scale (SECA 700, Hamburg, Germany).  Cardiorespiratory fitness was 
assessed using a modified Balke protocol 
181
, which is an incremental exercise test to volitional 
exhaustion on a treadmill, using indirect calorimetry (Cardio Coach CO2, Model 9002-CO2; KORR 
Medical Technologies, Salt Lake City, UT, USA).   
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For the second and third visits, participants were instructed to indicate their level of hunger 
immediately prior to exercise using a 150 mm visual analog scale that ranged between “I am not hungry 
at all” to “I have never been more hungry” 81.  Participants wore an electronic heart rate monitor (Polar 
FT1; Polar Electro Oy, FI-90440 Kempele, Finland) and exercised at either a moderate intensity (50-
70% age-predicted maximum heart rate - HRmax) or vigorous intensity (70-85% HRmax) (CDC, 2011) for 
20 minutes on a treadmill, with an additional 2.5 minute warm-up and 2.5 minute cool down.  The trials 
were conducted in a random order.  VO2 measures were averaged over 15 second intervals for the entire 
25 minute exercise protocol using indirect calorimetry (CardioCoach CO2, Model 9002-CO2, KORR 
Medical Technologies, Salt Lake City, Utah ) to calculate energy expenditure 
182
.  Approximately 10-20 
minutes post-exercise, participants again indicated their level of hunger using the same 150 mm visual 
analog scale, and were asked to estimate how many calories they expended during the entire 25 minute 
protocol.  Subsequently, participants were presented with a variety of pre-weighed foods, including 
whole wheat sliced bread, sliced turkey, cheese, mayonnaise and mustard, pasta with pasta sauce, 
chicken breast, salad, Italian salad dressing, Ranch salad dressing, and chocolate candy.  They were 
verbally instructed to create a meal, using any combination of the foods provided, that was equivalent to 
the number of calories that they estimated to have expended during the exercise bout.  The participants 
were informed that they did not have to consume the meal they created, but that they had the option of 
eating any of the food once the task was complete.   The foods chosen were then weighed with an 
electronic scale (Ohaus, Model V11P15, Ohaus Corporation, Pine Brook, New Jersey) to the nearest 
gram, and the caloric content of the food was calculated using the nutrition information provided on the 
food packaging.  Any food that the participants did consume was covertly recorded, and their ad libitum 
energy intake was calculated.   
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Statistical Analyses 
Differences in baseline characteristics between the 4 groups were assessed using 
ANOVA for continuous variables and chi-square tests for categorical variables.  The main 
outcome variables were measured energy expenditure, estimated energy expenditure, measured 
food energy, and food energy consumed in the ad libitum meal.  The error in calorie estimation 
was determined as both the mean difference as well as the absolute difference between the main 
outcome variables. Differences in the main outcome variables, as well as for the error in calorie 
estimation were assessed with a 4 x 2 (group x intensity) mixed models repeated measures 
ANOVA with post hoc tests.  Due to either time constraints or dietary preferences, only 41 out of 
the 58 participants chose to eat a post exercise meal.  Therefore, differences between calories 
consumed and energy expended were analyzed only in this subsample.  Alpha was considered 
statistically significant at P<0.05.  All analyses were performed in SAS version 9.4 (SAS 
Institute, Cary, North Carolina). 
 
Results  
Characteristics of the 58 participants are shown in Table 6.1.  The NW-noWL group had 
a significantly lower BMI, and higher cardiorespiratory fitness compared to the OW groups (P < 
0.05).   All groups exercised at a similar percentage of HRmax during the moderate condition 
(62.6 ± 4.5% HRmax) and vigorous condition (75.3 ± 5.4% HRmax). As expected, all groups 
expended significantly more calories during the vigorous condition (mean 207.2 ± 79.5 kcal) 
than the moderate condition (mean 152.6 ± 57.0 kcal), over the 25 minutes of exercise 
(P<0.001).  There were also no differences in hunger pre to post exercise within or between any 
of the groups (data not shown).     
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There were no within group differences in the moderate exercise intensity condition 
between estimated and measured energy expenditure, or calories in food (Figure 6.1A, P>0.05).  
In the vigorous exercise intensity condition, OW-noWL overestimated energy expenditure by 
72%, and overestimated the calories in their food by 37% relative to the measured energy 
expenditure (Figure 6.1B) (P<0.05).  In both exercise conditions, all groups, except for OW-
WL, consumed nearly double the calories in the ad libitum meal compared to the calories they 
expended during exercise (Figure 6.1 A+B) (P<0.05).   
  Differences in the mean error and absolute error of calorie estimation are presented in 
Table 6.2 and Table 6.3, respectively.  Following moderate intensity exercise, there were no 
differences between groups in the mean error of calorie estimation of exercise or food (P>0.05).   
Although the mean error in selecting food calories to match moderate intensity energy 
expenditure did not differ between groups (P>0.05), the number of calories in the food ranged 
from 88% under to 273% over what was actually expended (Table 6.2).  As well, the absolute 
error in calorie estimation was significantly greater than zero for all groups for all comparisons, 
with no differences between the groups (Table 6.3).   
  Following vigorous intensity exercise, OW-noWL overestimated energy expenditure to a 
greater degree compared to all other groups (P<0.05) (Table 6.2), and also significantly 
overestimated calories in food compared to both WL groups (P<0.05) (Table 6.2).   Although 
the mean error in selecting food calories to match vigorous intensity energy expenditure did not 
differ between groups (P>0.05), the number of calories in food ranged from 106% under to 
339% over what was expended (Table 6.2).  As well, the absolute error in calorie estimation was 
significant for all groups for all comparisons (P<0.05), with OW-noWL having a higher absolute 
error in estimating energy expenditure compared to the NW groups (P<0.05) (Table 6.3).   
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Discussion  
  The present study is the first to show that current weight status, intention to lose weight, 
and exercise intensity, are all associated with exercise and food calorie estimation.  In particular, 
those with elevated body weight who are not attempting to lose weight appear to be more prone 
to errors in estimating energy expenditure and energy in food following vigorous exercise.  
Although on average participants were able to match energy in food to energy expended during 
exercise, there was a considerable range of over and underestimation within all groups, as 
reflected by the large absolute error in calorie estimation of exercise and food.  Overall, these 
findings demonstrate an overall poor ability to estimate energy expended through exercise, and 
calories in food, which may have important implications for weight management.   
  Given the popular theory that excess energy intake is the primary driver of the obesity 
epidemic 
183
, it is important to investigate if individuals have an understanding of the caloric 
content of food.  In the present study, only OW-noWL overestimated food calories by 68%, 
while all other groups underestimated food calories by ~25%, after vigorous exercise.  This 
extends the work of Carels et al. (2006) who reported that a higher baseline BMI was associated 
with greater error in calorie estimation 
80
, as we demonstrate that weight loss status may 
significantly alter calorie estimation.  In contrast to previous research that has demonstrated that 
adults generally underestimate calories in food 
76,81,179
, we demonstrate that the mean error 
between estimated and actual calories in food was similar, there was a large inter-individual 
range in the errors observed.  However, this may be in part due to the actual caloric content of 
the meals being relatively small, as a previous study reported that adults consistently 
underestimate calories in large meals, yet are reasonably accurate at estimating calories in small 
meals 
184
.  Nevertheless, the interpretation that adults are accurate at estimating calories in food 
70 
 
may be misleading as there was a considerable amount of individual variability among all groups 
that ranged from a 760 kcal underestimation to a 468 kcal overestimation of calories in food.  
Given that an understanding of calories consumed and expended are both important factors for 
successfully maintaining long term weight loss 
185
, a lack of understanding in either of these 
components of energy balance may lead to problems with weight management. 
  Studies that have investigated whether BMI or dieting status influences accuracy of 
exercise energy expenditure estimation have shown mixed results.  For example, among NW 
adults, there have been reports of both overestimation 
81
 as well as underestimation 
82
 of 
moderate energy expenditure. As well, Visona and George (2002) reported that OW adults who 
were dieting underestimated moderate energy expenditure, while non-dieters overestimated 
moderate energy expenditure 
75
.  Conversely, our results demonstrate that on average both NW 
and OW adults accurately estimated moderate intensity expenditure, regardless of whether or not 
they were attempting weight loss. However, due to the wide range of under and overestimation, 
all groups had a significantly large absolute error in estimation of moderate energy expenditure 
that ranged between 57 and 104 kcal.  On the other hand, the only other study to investigate how 
exercise intensity influences calorie estimation reported that  NW adults underestimate moderate 
intensity expenditure, but accurately estimate high intensity expenditure 
82
.  This is in contrast to 
the present study, in which the mean difference between estimated and measured energy 
expenditure was not different for NW adults for either moderate or vigorous exercise.  However, 
OW-noWL overestimated vigorous energy expenditure, and to a significantly greater degree 
compared to all other groups. Yet, OW-noWL also overestimated the energy content of their 
meals, and despite their larger errors, were able to match energy in food with energy expended 
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through exercise.  Thus, the complex association between calorie estimation and weight 
management may require further investigation.   
    It is recommended that in order to maintain a healthy body weight, individuals must be 
able to correctly match energy intake with energy expenditure 
186
.  In one study by Willbond et 
al. (2010), it was reported that NW adults chose post exercise meals that contained 2-3 times the 
number of calories than what was expended during moderate intensity exercise 
81
.  Conversely, 
Holliday and Blannin (2014) demonstrated that NW participants were able to accurately match 
calories in a post exercise meal to the energy expended during moderate and high intensity 
exercise 
82
.  The present study extends these previous findings by including both NW and OW 
adults who were and were not attempting weight loss.  Regardless of BMI or weight loss status, 
these findings are in accordance with those of Holliday and Blannin (2014), in that on average 
participants were able to match calories in a post exercise meal to the energy expended during 
moderate and vigorous intensity exercise.  However, again there was a large variability in the 
individual accuracy, as some individuals constructed meals that contained 220kcal less, to 543 
kcal more than the number of calories they expended during exercise. Given that the higher rates 
of overweight and obesity today compared to 30 years ago is estimated to be due to an energy 
surplus of 370 kcal/day 
187
, the observed error in calorie estimation in the present study may help 
explain why many adults struggle with weight management.      
  Although participants accurately matched calories in food to calories expended during 
exercise, most individuals consumed significantly more calories in a post exercise ad libitum 
meal compared to the energy they expended.  This finding is consistent with other studies 
76,82
 
even though there were fewer food options in the present study compared to the large buffet type 
meals that others have provided.  Interestingly, OW-WL was the only group that did not 
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consume more calories than they expended.  This may have been due to the fact that this group 
was trying to lose weight and therefore may have a better understanding of calories and were 
consciously restricting their caloric intake.  In contrast, NW-WL consumed nearly double what 
they expended, with some of these individuals consuming up to 5 times the number of calories 
that they burned during exercise.   However, because diet was not tracked over time, we cannot 
infer that the amount of food that was eaten represents a typical meal or daily intake for these 
individuals.   
  Although it has been reported that knowledge of calories is important for weight 
management, it is possible that even if individuals do have an understanding of calories, this may 
not influence their food choices. For example, recent legislation in the United States requiring 
restaurants to post calorie information for regular food and drink items 
188
 has not resulted in 
consumers purchasing lower calorie meals,  
189,190
, even when they notice the available calorie 
information 
191
.  Further research is needed to investigate the association between calorie 
estimation and weight management.    
  Strengths and limitations of this study warrant mention.  Unlike other studies that used 
predictive equations to determine exercise energy expenditure 
75,76
, the current study used 
indirect calorimetry, which accounts for individual variability in economy 
77
. This is also the first 
study to examine the joint effects of BMI class, weight loss status, and exercise intensity on 
calorie estimation.  Although the groups were not balanced, the repeated measures ANOVA 
were conducted with the PROC MIXED procedure, which has the capacity to handle unbalanced 
data.  Further, the current sample is significantly larger than past studies 
81,82
.  Though there were 
several non-significant differences between groups, these differences are likely not clinically 
relevant (i.e. measured food energy – measured energy expenditure: 7 to 25 kcal) given the 
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proposed caloric surplus hypothesized to be responsible for the rise in obesity prevalence 
187
.  A 
retrospective sample size analysis determined that this study would have needed a minimum of 
252 participants per group to see statistically significant group differences.  Although 
information for %HRpeak was available, we chose to calculate exercise intensity based on 
predicted %HRmax, as the majority of individuals would not have access to incremental exercise 
testing and would have to rely on age-predicted formulas to calculate exercise intensity.  
However, the %HRmax was 4.9% higher than the %HRpeak, and thus the magnitude of difference 
has minimal clinical relevance.  The present study was also unable to distinguish between 
participants with overweight versus obesity.  As well, although there was a range of common 
foods, it is possible that the food provided was not representative of what all of the participants 
typically eat.  Although there were group differences in age and ethnicity, there is currently no 
literature to suggest that either of these variables would influence ability to estimate calories. 
Finally, because participants engaged in aerobic exercise only, these results may not be 
generalizable to other forms of exercise.  
  In conclusion, BMI, weight loss status, and exercise intensity, may all be 
important factors to consider when investigating calorie estimation.  There was a large degree of 
variability in error of calorie estimation for both exercise and food, indicating that many 
individuals have a poor understanding of calories.  Nevertheless, the large observed errors in 
calorie estimation even in individuals who are attempting to lose weight is concerning, and may 
be a potential contributor to the generally poor weight loss success observed when attempted 
through diet and exercise. 
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Table 6.1.  Subject characteristics according to BMI class and weight loss status.   
 
 
a
 = significantly different compared to the NW-noWL group (P<0.017). 
b
 = significantly 
different from the NW-WL group (P<0.017).   NW = normal weight, WL = attempted weight 
loss, BMI = body mass index, WC = waist circumference, VO2 = volume of oxygen.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 NW-noWL NW-WL OW-noWL OW-WL 
N 18 12 13 15 
Age (years) 21.6 ± 2.5 27.6 ± 11.8 27.3 ± 13.9 35.3 ± 15.7 
a
 
Sex (% male) 38.9 33.3 38.5 26.7 
Ethnicity (% white) 50.0 66.7 38.5 73.3 
BMI (kg/m²) 21.4 ± 2.3 23.1 ± 1.6  27.8 ± 2.8 
ab
 28.4 ± 2.6 
ab
 
VO2 peak 
(ml/kg/min) 
49.8 ± 10.2 42.0 ± 11.5 33.7 ± 10.7 
ab
 35.3 ± 11.8 
a
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Table 6.2. Mean error in estimating exercise energy expenditure and calories in food by BMI and weight loss status.    
 
 
Differences are presented as mean ± standard deviation (range).  BMI = body mass index; NW = normal weight; OW = 
overweight/obese; WL = weight loss; EE = energy expenditure; kcal = kilocalories; EI = energy intake.  * = significantly different 
compared to the OW-noWL group (P<0.05).   
  
 NW-noWL NW-WL OW-noWL OW-WL 
Kilocalories Moderate Intensity Condition  
Estimated energy expenditure - 
Measured energy expenditure 
2 ±125  
(-97 to 444) 
-43 ± 48   
(-123 to 50)   
37 ± 149 
(-109 to 321) 
-24 ± 104  
(-177 to 198) 
Estimated food energy – measured 
food energy  
-28 ± 91  
(-195 to 188) 
-54 ± 89  
(-280 to 32) 
40 ± 145  
(-135 to 404) 
-40 ± 111  
(-218 to 123) 
Measured food energy – measured 
energy expenditure 
29 ± 123 
(-135 to 319) 
11 ± 90 
(-105 to 213) 
-3 ± 66 
(-83 to 142) 
17 ± 146 
(-133 to 417) 
Measured energy intake –measured 
energy expenditure 
157 ± 179 
(-85 to 478) 
187 ± 242 
(-52 to 678) 
171 ± 215 
(-69 to 554) 
109 ± 230 
(-133 to 467) 
 Vigorous Intensity Condition  
Estimated energy expenditure - 
Measured energy expenditure 
-2 ± 117 * 
(-167 to 361) 
-53 ± 72 * 
(-187 to 102) 
150 ± 271  
(-87 to 754) 
4 ± 145 * 
(-279 to 274) 
Estimated food energy – Measured 
food energy  
-21 ± 139 * 
(-306 to 243) 
-66 ± 97 * 
(-302 to 50) 
96 ± 194 
(-215 to 468) 
-51 ± 224 * 
(-760 to 176) 
Measured food energy – Measured 
energy expenditure 
20 ± 147 
(-220 to 416) 
13 ± 116 
(-104 to 284) 
54 ± 174 
(-112 to 543) 
55 ± 206 
(-172 to 702) 
Measured energy intake – Measured 
energy expenditure 
180 ± 169 
(-45 to 431) 
203 ± 290 
(-87 to 787) 
147 ± 210 
(-70 to 531) 
59 ± 147 
(-69 to 410) 
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Table 6.3. Absolute error in estimating exercise energy expenditure and calories in food by BMI and weight loss status.    
 
 
Differences are presented as mean ± standard deviation (range).  BMI = body mass index; NW = normal weight; OW = 
overweight/obese; WL = weight loss; EE = energy expenditure; kcal = kilocalories; EI = energy intake.  * = significant absolute error 
within a group (P<0.05); † = significantly different compared to the OW-noWL group (P<0.05). 
 NW-noWL NW-WL OW-noWL OW-WL 
Kilocalories Moderate Intensity Condition  
Estimated energy expenditure - 
Measured energy expenditure 
77 ± 97 * 
(9 to 444) 
57 ± 27 * 
(27 to 123)   
104 ± 110 * 
(6 to 321) 
88 ± 56 * 
(2 to 198) 
Estimated food energy – measured 
food energy  
78 ± 56 * 
(12 to 194) 
66 ± 79 * 
(1 to 280) 
100 ± 110 * 
(35 to 404) 
98 ± 62 * 
(16 to 218) 
Measured food energy – measured 
energy expenditure 
88 ± 89 * 
(5 to 319) 
66 ± 58 * 
(4 to 213) 
53 ± 37 * 
(110 to 142) 
103 ± 101 * 
(7 to 417) 
Measured energy intake –measured 
energy expenditure 
157 ± 179 * 
(5 to 478) 
200 ± 230 * 
(28 to 787) 
207 ± 177 * 
(23 to 554) 
171 ± 182 * 
(7 to 467) 
 Vigorous Intensity Condition  
Estimated energy expenditure - 
Measured energy expenditure 
78 ± 85 *†  
(10 to 361) 
72 ± 52 *† 
(8 to 187) 
198 ± 235 * 
(24 to 754) 
120 ± 75 * 
(1 to 279) 
Estimated food energy – Measured 
food energy  
96 ± 100 * 
(5 to 305) 
84 ± 80 * 
(19 to 302) 
157 ± 146 * 
(3 to 468) 
139 ± 180 * 
(15 to 760) 
Measured food energy – Measured 
energy expenditure 
102 ± 105 * 
(4 to 416) 
89 ± 70 * 
(6 to 284) 
110 ± 143 * 
(9 to 543) 
123 ± 172 * 
(10 to 702) 
Measured energy intake – Measured 
energy expenditure 
180 ± 169 * 
(45 to 431) 
235 ± 259 * 
(28 to 787) 
169 ± 190 * 
(9 to 531) 
90 ± 128 * 
(10 to 410) 
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Figure 6.1.  Measured exercise energy expenditure (black bars), estimated exercise energy expenditure (dark grey bars), measured 
food energy (light grey bars), and ad libitum energy intake (white bars) following moderate intensity exercise (Panel A) and vigorous 
intensity exercise (Panel B), according to BMI and weight loss status.  Data is presented as mean ± standard error.  NW = normal 
weight; OW = overweight/obese; WL = weight loss; * = significantly different from measured energy expenditure within a group 
(P<0.05). † = significantly different from estimated energy expenditure within a group (P<0.05).   
Figure 6.1 
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Chapter 7. Manuscript 5: Waist Circumference at Five Common Measurement Sites in 
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Abstract 
Objectives: To determine 1) if adults would measure their own WC, 2) which WC site(s) are 
most intuitive and easy to measure, and 3) if measurement accuracy, as well as the association 
between WC and blood pressure, differs across five measurement sites.  Methods:  Participants 
(n=198; 26.3±12.4 years) measured their WC first with no instruction, and then using visual 
instructions for the iliac crest, last rib, midpoint, minimal waist, and umbilicus. Technicians 
repeated the measurements at the same locations.   Results:  Only 58-68% of females reported 
that they would measure their own WC compared to 78-92% of males.  Without instruction, 
participants most commonly measured their WC at the umbilicus or iliac crest.  The minimal 
waist and umbilicus were reported to be moderately easier to self-measure compared to the iliac 
crest and midpoint (P<0.05).  Prevalence of abdominal obesity varied significantly by sex and 
measurement site, especially for females (normal weight: 0-18%; overweight: 51-79%).  
Measurement site did not influence accuracy of WC self-measurement, or the association 
between WC and blood pressure (P>0.05).  Conclusion:  All five WC measurement sites are 
reasonable to recommend as we did not observe a clear clinical or practical advantage of 
measuring one WC site over another.  However, to fairly compare WC measurements between 
studies, a universal WC landmark is needed.   
 
Key Words: Blood Pressure, Abdominal Obesity; Body Composition; Body Mass Index 
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Introduction 
Abdominal obesity is associated with adverse health outcomes, such as hypertension, 
diabetes, dyslipidemia, and the metabolic syndrome, independent of total adiposity.
9,51
  Waist 
circumference (WC) is now widely acknowledged as a simple and reliable measure of abdominal 
obesity and predictor of metabolic health risk.
53,54,192,193
  Although many health authorities 
recommend measuring WC in addition to body weight to monitor weight-related health risk,
5,57
 
there is not yet a universal standard protocol for measuring WC.  For example, the World Health 
Organization and the International Diabetes Federation recommend measuring WC at the 
midpoint between the superior border of the iliac crest and the last rib,
194,195
 whereas the National 
Institutes of Health recommends measuring WC at the superior border of the iliac crest.
57
  Other 
commonly used measurement sites include the minimal waist, umbilicus, and last rib.
58
   
Several studies have reported that the WC,
61,63,64
 as well as the prevalence of abdominal 
obesity,
61
 is significantly influenced by the WC measurement site.  However, the measurement 
site that is most strongly associated with health risk is not clear.  Moreover, if health agencies 
wish to promote WC measurement as a way to monitor health risk, it is important to know if and 
where adults can accurately measure their WC.  Investigations of whether adults can accurately 
measure their own WC, or if measurement accuracy is influenced by body weight status  has 
resulted in mixed findings.
196–198
  Furthermore, it is currently not known if certain measurement 
sites are more difficult to measure than others from the patient’s perspective.  Therefore, the 
objectives of this study were to determine 1) if individuals are willing to measure their own WC, 
2) which WC measurement site(s) adults naturally measure, 3) which WC measurement site(s) 
adults find the easiest or hardest to self-measure, 4) if individuals can accurately measure their 
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WC at five commonly measured WC measurement sites, and 5) which WC measurement site(s) 
is most strongly associated with blood pressure.     
 
Methods 
Participants 
Participants were 198 adults between 18-65 years who were recruited via poster 
advertisement from a large urban university setting (n=184), and from a medical weight 
management clinic (n=14).  Participants were excluded from the blood pressure analyses if they 
reported taking medications for hypertension (n=5) or if they were missing information for blood 
pressure (n=15), leaving a sample size of 178 adults.  Prior to the assessment, participants were 
instructed to refrain from exercising for at least 24 hours, and to refrain from eating or drinking 
anything with caffeine for at least 2 hours.  Written informed consent was obtained from all 
participants, and all procedures in this study were approved by the local university ethics board 
and conformed to the Declaration of Helsinki.   
Blood Pressure and Anthropometric Measurements  
Blood pressure was measured with an automatic blood pressure machine (BpTRU 
Medical Devices, Model BPM-200, Coquitlam, BC, Canada) six times, with one minute between 
each measurement.  The first measurement was discarded and the final blood pressure was an 
average of the final five measurements.  Height was measured with a stadiometer (Seca 
Telescopic Height Rod, Model 220, Hamburg, Germany), and weight was measured with a 
mechanical scale (SECA 700, Hamburg, Germany).   Participants were categorized as either 
normal weight (NW; BMI ≥18 and <25 kg/m²), or overweight (OW; BMI ≥ 25 kg/m²).  Body fat 
percentage was assessed as the average of two bioelectrical impedance analyzers (Tanita Body 
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Composition Analyzer, Model BC-418, Tanita Corporation, Tokyo, Japan, and Omron Fat Loss 
Monitor, Model HBF-306C, Omron Healthcare, Inc., Bannockburn, Illinois).   
First, participants were asked to measure their WC with no instruction using a tension-
sensitive non-elastic tape measure, and location of measurement was recorded by the 
investigator.  Subsequently, participants measured their WC at five commonly measured 
anatomical sites using simple visual and written instructions in a random order: the superior 
border of the iliac crest, the last rib, the midpoint between the superior border of the iliac crest 
and the last rib, the minimal waist, and the umbilicus.  After each measurement, participants 
were asked, “On a scale of 1 to 5, 1 being easy, and 5 being difficult, how easy or difficult was it 
to measure your waist at that site?” Participants were also asked the following questions: “Would 
you measure your own WC in addition to your body weight, and why?”, and “Would you 
measure your own WC if it were a better predictor of your health than your body weight, and 
why?”  Waist circumference was then measured twice by a different investigator at the same five 
anatomical sites.  
Statistical Analyses 
All analyses were performed separately for males and females.  Differences in baseline 
characteristics by BMI status were assessed with ANOVA for continuous variables and chi-
square tests for categorical variables.   Differences between self- and technician-measured WC, 
differences in WC between sites, and differences in measurement difficulty scores between sites, 
were compared with repeated measures ANOVA.  The degree of reproducibility between self- 
and technician measured WC at each measurement site was determined using intra-class 
correlation coefficients (ICC).   For illustrative purposes,  Bland-Altman plots were used to 
illustrate WC measurement agreement between the participant and the technician, and to 
83 
 
investigate measurement bias.
199
  Pearson correlations were used to determine the associations 
between SBP and DBP with WC, as well as the associations between self- and technician-
measured WC, at each measurement site.  The associations between blood pressure and WC 
were adjusted for age and ethnicity.  Differences in the strength of the correlations between 
blood pressure and WC at each measurement site were determined with Steiger’s Z test,200 with 
Bonferroni adjustments for multiple comparisons.  All statistical analyses were performed with 
SAS version 9.4 (SAS Institute, Cary, North Carolina).  
Results 
 Characteristics of the participants by sex and BMI class are shown in Table 7.1.  Females 
who were OW had a higher SBP, and were less likely to report that they would measure their 
own WC even if WC was a better predictor of health, compared to NW (P<0.05).  Of the 
individuals who indicated they would measure their own WC, the most common rationales were 
that WC gave a better indication of body fat distribution (45%), and that both WC and body 
weight were important measures for health (27%).  Of the individuals who reported that they 
would not measure their own WC, the most common rationales were that they did not consider 
WC to be an important measurement (49%) and that they did not care about their WC 
measurement (41%).   
Regardless of BMI, the majority of males naturally measured their WC without 
instruction at the iliac crest or the umbilicus, whereas half of the females naturally measured 
their WC at the umbilicus (Table 7.2). None of the WC measurement sites were rated as 
particularly difficult to measure as all sites had a measurement difficulty score that ranged 
between 1.8 to 2.9 out of 5 (Table 7.2).  However, both the minimal waist and the umbilicus 
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were rated to be modestly easier to measure compared to the commonly clinically recommended 
sites (i.e. iliac crest and midpoint (P<0.05).   
In males with OW, WC values were similar between measurement sites (P>0.05).  
Among NW males and all females, WC varied significantly between measurement sites, with the 
largest values typically at the iliac crest or umbilicus (Table 7.2).    In NW, 10% (technician-
measured) and 18% (self-measured) of females had a high WC when measured at the iliac crest 
while the prevalence of high WC was 0-6% at all other sites (Table 7.2).  In OW, the prevalence 
of high WC was 21-78%, with 12-15% more adults were classified as having a high WC at the 
iliac crest or umbilicus compared to the minimal waist.   
Intra-class correlations coefficients were high at all sites for individuals with OW (males 
0.954-0.971 and females 0.921-0.943), and more variable among individuals with NW (males: 
0.748-0.932 and females: 0.460-0.680) (Table 7.2).  Self- and technician-measured WC were 
strongly correlated at all measurement sites, with R² ranging between 0.91-0.95 for males 
(Figure 7.1) and between 0.87-0.91 for females (Figure 7.2).  Self- and technician-measured 
WC did not differ in either males or females at any measurement site (P>0.05) (Figure 7.1 and 
7.2).  However, the 95% limits of agreement were wide, particularly in females (Males: -6.7 to 
8.8 cm; Females: -11.9 to 12.3 cm).  For most sites, there was no evidence of a systematic 
measurement bias (P>0.05).  However, for males, there was a small but statistically significant 
over self-measurement at the last rib with increasing WC (R² = 0.04, P = 0.04 (Figure 7.1F), and 
for females, a small but statistically significant under self-measurement at the umbilicus with 
increasing WC (R² = 0.04, P = 0.03), (Figure 7.2J).   
 In both sexes, the association between systolic blood pressure and WC (males: r = 0.13 – 
0.18, P>0.05; females: r = 0.21 to 0.26, P<0.05) and diastolic blood pressure and WC (males: r = 
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0.02 to 0.04, P>0.05; females: r = 0.20 to 0.26, P<0.05) did not differ between any measurement 
site (P>0.05).  Correlations between blood pressure and self-measured WC were similar to 
correlations with technician-measured WC.    
Discussion 
 The present study provides evidence that the iliac crest and umbilicus may be the most 
intuitive WC sites to measure, and that there are minimal differences in the difficulty and 
accuracy of self-measured WC at the different sites.  Although the absolute WC size and the 
prevalence of abdominal obesity are influenced by WC measurement site, the association 
between WC and blood pressure did not differ between WC measurement sites.  Therefore, there 
does not appear to be one most optimal WC measurement site that provides a significant clinical 
or practical advantage.      
In the current study that consisted of primarily university educated adults, 73-91% 
indicated that they would be willing to measure their own WC if it was a better predictor of 
health risk than body weight.  However, in a study of the general population, only 50% said they 
would be willing and only 1% reported routinely measuring their own WC.
201
  It is not surprising 
that many individuals do not consider WC to be an important measurement for their health, as 
few primary care physicians measure WC in clinical practice, or inform even high-risk patients 
of the health consequences associated with abdominal obesity.
201
  Thus, although WC is a simple 
measurement that can be used to monitor weight-related health risk independently of body 
weight, it is clear that some individuals still do not consider their WC to be a meaningful 
measure of their health, and would not measure WC even if they believed it was. Given the 
strong evidence linking abdominal obesity to deleterious cardiometabolic health,
202
 greater effort 
may be needed to promote the routine measurement of WC in health care and the general public.     
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The present study is the first to show that while none of the WC sites were rated as 
particularly difficult to measure, the clinically recommended iliac crest and midpoint were rated 
as moderately more difficult to measure compared to the minimal waist and umbilicus. The 
umbilicus was also the most intuitive measurement site for approximately half of the 
participants.  However, the umbilicus may be inappropriate to use for certain individuals with 
greater abdominal obesity due to an enlarged pannicular fold that results in the downward 
translation of the umbilicus.
61
  Indeed, it is not unusual to observe WC measures at the umbilicus 
to be more akin to the level of the hip or even upper thigh.  Thus, there does not appear to be a 
sufficient practical advantage to suggest a change in WC measurement.  However, given that the 
WC site that participants intuitively measured was highly variable, a universal WC landmark and 
education of the general public about WC self-measurement is needed.   
Whether or not adults can accurately measure their WC is important to determine prior to 
promoting the self-measurement of WC among the general public.  Most studies that have 
reported that there is no difference between self- and technician-measured WC derived this 
conclusion using correlation coefficients,
197,198,203
 which may be misleading given that 
correlations only assess the strength of the relationship between two variables, and not the 
agreement between them.
199
  In the present study, we observed strong correlations as well as 
similar values between self- and technician-measured WC at all measurement sites. To our 
knowledge, we are also the first to observe that the degree of measurement reproducibility was 
high among adults with OW, but lower and more variable among those with NW.  However, the 
high intra-class correlations among those with OW is encouraging given that individuals with 
OW or obesity are most likely to benefit from self-monitoring of WC measures.  We also 
observed wide limits of agreement between the self- and technician measured WC, especially for 
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females, indicating a considerable degree of under and over measurement of WC at all sites.  
Furthermore, while it has been reported that waist size does not influence the ability of females 
to measure their WC at the minimal waist,
197
 others have demonstrated that under self- 
measurement of WC is greater with increasing waist size for both sexes at the umbilicus,
196
 as 
well as the midpoint.
203,204
  In the present study, we observed that with increasing waist size, 
there was an over self-measurement of WC at the last rib in males, such that the maximum bias 
observed between those with the highest and lowest WC was ~ 3 cm, and an under self-
measurement of WC at the umbilicus in females (maximum bias ~4 cm).  However, although 
these biases were statistically significant, they are likely not clinically relevant as most 
individuals would be within the reported measurement error for WC.
204
  Therefore, accuracy of 
WC self-measurement is variable, but does not appear to differ by WC measurement site. 
The now widely used WC cut-offs of 102 cm in males and 88 cm in females were 
originally determined using WC measured at the midpoint,
205
 which is the recommended WC 
measurement site of the World Health Organization.
194
  The iliac crest is the recommended WC 
measurement site in Canada and the United States,
5,57
 and is typically a higher absolute WC 
value compared to the midpoint in females, but not males.
62,63,66
  Therefore, larger WC cut-offs 
may be needed in women if using the iliac crest.  The universal use of cut-points made using WC 
measures at the midpoint has potentially large impacts on estimates of abdominal obesity 
between studies using different measurement sites.  Indeed, we observed the prevalence of 
abdominal obesity in OW ranged from ~21% to 78% depending on sex and measurement site, 
and indicates that even small variations in WC can influence the prevalence of abdominal obesity 
when dichotomous cutoffs are used.
61,62,65
  Therefore, measurement site should be taken into 
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consideration when attempting to compare studies that report the prevalence of abdominal 
obesity.       
In the present study, the association between blood pressure and WC was not dependent 
on WC measurement site. This finding is consistent with that of Mason et al.
206
 who 
demonstrated that several metabolic risk factors, including blood pressure, were similarly 
associated with WC measured at the iliac crest, midpoint, last rib, and minimal waist in a sample 
of primarily white adults.  In contrast, WC measurement at the midpoint was reported to be 
superior compared to measurement at the iliac crest in its association with diastolic blood 
pressure in overweight females (r = 0.38 versus 0.31),
62
 and with systolic blood pressure in 
Asian adults (males: r = 0.27 versus 0.23; females: r = 0.37 versus 0.34),
66
 which translates into 
an additional 2-5% variance explained with the midpoint than the iliac crest. With few 
exceptions, even in the statistically significant observations, the advantages of one WC site over 
another in predicting blood pressure and other metabolic risk factors is minimal,
62,65,66,206
 and is 
unlikely to be of a magnitude that is clinically relevant.   
The major strength of this study is that we examined both practical and clinical aspects of 
WC measurement at five commonly used sites.  However, our investigation of associations 
between WC and metabolic risk was limited to blood pressure.  We also did not have enough 
individuals with a BMI ≥ 30 kg/m² to be able to discriminate between those with overweight 
versus obesity.   
In conclusion, there were minimal differences in the ease or accuracy of WC self-
measurement among five commonly used WC measurement sites.  Waist circumference 
measurement site significantly influenced both WC size and the prevalence of abdominal 
obesity, but not the association between WC and blood pressure.   Thus, all five WC 
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measurement sites are reasonable to recommend as we did not observe any clear clinical or 
practical advantages for one WC measurement site over another.  However, in order for WC 
measurement to be comparable between studies, a universal WC landmark is needed.      
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Table 7.1.  Subject characteristics by sex and weight class 
 
 
Data is presented as means (SD) unless otherwise indicated.  NW = normal weight; OW 
=overweight; WC = waist circumference.  * = significantly different compared to normal weight 
group within each sex (P<0.05).   
 Males Females 
 NW OW NW OW 
N 49 33 69 47 
Age (years) 22.2 (5.2) 25.6 (12.4)* 22.0 (6.5) 35.8 (16.5)* 
Ethnicity (%)      
White 67 52 46 60 
Black  3 12 10 19 
Asian 16 30 33 15 
Other 14 6 10 16 
BMI (kg/m²) 22.2 (1.8) 28.4 (3.6)* 21.5 (1.9) 30.0 (4.5)* 
Body Fat (%) 10.7 (4.1) 23.8 (6.4)* 21.5 (4.3) 36.8 (7.4)* 
SBP (mmHg) 119 (8) 119 (9) 111 (10) 118 (13)* 
DBP (mmHg) 74 (8) 74 (8) 71 (7) 75 (9) 
Would measure 
their own WC 
(%) 
77.6 90.9 68.1 57.5 
Would measure 
their own WC if 
better predictor 
of health than 
body weight 
(%) 
89.8 90.9 91.2 73.3* 
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Table 7.2.  Waist circumference, prevalence of high waist, and measurement difficulty score according to waist circumference 
measurement site.   
 Iliac Crest Midpoint Last Rib Minimal Waist Umbilicus 
Male NW 
Self-measured WC (cm) 79.5 (5.6) 77.5 (5.3) 76.5 (6.0)
a
 76.2 (6.0)
a
 77.4 (5.7) 
Tech-measured WC (cm) 77.9 (6.0) 76.6 (6.0) 76.2 (5.6) 75.5 (5.7)
ab
 78.0 (5.8) 
ICC between Self and Tech 
WC 
0.748 0.822 0.930 0.854 0.932 
High Waist Tech (%) 4.1 4.1 2.0 2.0 4.1 
High Waist Self (%) 4.1 4.1 2.0 4.1 4.1 
Measurement difficulty score  2.4 (1.0) 2.6 (0.8) 2.6 (1.0) 2.1 (0.8)
abc
 1.9 (0.8)
abc
 
Naturally measured WC (%) 40.0 4.4 4.4 6.7 44.4 
      
Male OW  
Self-measured WC (cm) 94.1 (13.6) 93.0 (14.4) 91.8 (13.9) 90.8 (12.9) 93.1 (13.2) 
Tech-measured WC (cm) 93.8 (13.7) 92.1 (14.0) 90.8 (13.1) 89.5 (12.5) 94.1 (14.2) 
ICC between Self and Tech 
WC 
0.965 0.971 0.963 0.954 0.956 
High Waist Tech (%) 36.4 30.3 27.3 21.2 33.3 
High Waist Self (%) 33.3 33.3 24.2 30.3 39.4 
Measurement difficulty score 2.6 (1.1) 2.8 (1.2) 2.5 (1.1) 2.0 (0.9)
ab
 1.9 (1.0)
abc
 
Naturally measured WC (%) 51.5 3.0 0 0 45.5 
      
Female NW  
Self-measured WC (cm) 78.4 (6.0) 72.3 (6.3)
a
 69.1 (5.1)
abe
 69.2 (4.6)
abe
 73.5 (5.6)
a
 
Tech-measured WC (cm) 76.5 (6.4) 72.4 (5.5)
a
 70.0 (5.3)
abe
 69.0 (4.9)
abe
 74.6 (5.9)
b
 
ICC between Self and Tech 
WC 
0.593 0.460 0.622 0.680 0.661 
High Waist Tech (%) 10.1 2.9 0 0 5.8 
High Waist Self (%) 18.8 5.8 1.5 1.5 4.4 
Measurement difficulty score 2.4 (0.9) 2.8 (1.0)
a
 2.6 (1.0) 1.8 (0.8)
abc
 2.0 (0.9)
abc
 
Naturally measured WC (%) 16.2 2.9 5.9 20.6 54.4 
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Female OW 
Self-measured WC (cm) 98.7 (15.9) 95.3 (15.4) 91.5 (15.3)
abe
 90.9 (14.9)
abe
 96.5 (14.4) 
Tech-measured WC (cm) 98.4 (16.1) 94.5 (15.0) 91.7 (13.8)
abe
 90.2 (13.4)
abe
 99.3 (15.4) 
ICC between Self and Tech 
WC 
0.940 0.936 0.931 0.943 0.921 
High Waist Tech (%) 78.2 61.7 55.3 53.2 78.7 
High Waist Self (%) 78.7 63.8 51.0 55.3 76.6 
Measurement difficulty score 2.5 (1.1) 2.9 (1.2) 2.9 (1.3) 2.2 (1.2)
bc
 2.0 (1.1)
abc
 
Naturally measured WC (%) 15.9 11.4 0 20.5 52.3 
 
Data is presented as means (SD) unless otherwise indicated.  High waist circumference was classified according to International 
Diabetes Federation criteria (white/black/other males: ≥ 102 cm; Asian males ≥ 90 cm; white black/other females: ≥ 88 cm; Asian 
females: ≥ 80 cm).  a = significantly different compared to the iliac crest (P<0.05), b = significantly different compared to the midpoint 
(P<0.05), 
c
 = significantly different compared to the umbilicus (P<0.05), 
d
 = significantly different compared to the last rib (P<0.05); 
e 
= significantly different compared to the umbilicus (P<0.05).  NW = normal weight; OW = overweight.  ICC = intra-class correlation 
coefficient.   
Note:  Measurement difficulty score was based on a 5 point scale, with 1 representing an easy measurement and 5 representing a hard 
measurement.   
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Figure 7.1 
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Figure 7.1. Associations between self-measured and technician-measured WC at five 
measurement sites in males (Panels A,C,E,G,I), and the agreement between the measures using 
Bland-Altman plots (Panels B,D,F,H,J).  Correlation plots have the line of best fit in black and 
the line of identity in grey.  Bland-Altman plots show the mean difference (solid line) and the 
95% limits of agreement (dotted line) between self- and technician-measured WC.  Significant p-
values indicate significant under or over measurement of participant measured WC.  Line of 
identity and significant r-squared values indicate a systematic difference between the measures.  
WC = waist circumference; IC = iliac crest; MP = midpoint; LR = last rib; MW = minimal waist; 
UM = umbilicus 
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Figure 7.2 
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Figure 7.2.  Associations between self-measured and technician-measured WC at five 
measurement sites in females (Panels A,C,E,G,I), and the agreement between the measures using 
Bland-Altman plots (Panels B,D,F,H,J).  Correlation plots have the line of best fit in black and 
the line of identity in grey.  Bland-Altman plots show the mean difference (solid line) and the 
95% limits of agreement (dotted line) between self- and technician-measured WC.  Significant p-
values indicate significant under or over measurement of participant measured WC.  Line of 
identity and significant r-squared values indicate a systematic difference between the measures.  
WC = waist circumference; IC = iliac crest; MP = midpoint; LR = last rib; MW = minimal waist; 
UM = umbilicus.   
 97 
 
Chapter 8: General Discussion  
Despite the well-known health benefits of PA in various ages and populations, physical 
inactivity is highly prevalent, and is now the fourth leading risk factor for mortality globally 
2
.  
Canada’s Physical Activity Guidelines recommend that adults accumulate 150 minutes of 
moderate or vigorous PA/week for health benefits, and that more activity is associated with 
additional health benefits 
11
.  A large systematic review that examined the association between 
PA and specific health outcomes demonstrated a strong dose-response relationship between PA 
and seven common chronic conditions, thus supporting the PA guideline recommendations 
207
.  
Additionally, there was a clear inverse association between PA and risk of premature mortality 
207
.  However, the greatest differences in mortality risk is observed between those participating in 
modest amounts of PA compared to those participating in no activity 
207
.  This is in line with 
several epidemiological studies who report that participating in PA even once a week is 
associated with lower mortality risk compared to participating in no PA  
19–22
.   
Indeed, findings from this dissertation indicated that among all ages, participating in 1-2 
bouts of PA/week was associated with lower all-cause mortality risk compared to participating in 
no PA.  However, among very old adults (aged 80+ years), participating in PA at least 5 
times/week was associated with a significantly lower risk of premature mortality compared to 
participating in less activity.  Therefore, a higher frequency of PA may be most beneficial for 
very old adults, who are coincidentally the age group that participates in the least amount of PA 
208
.  These findings support the previous PA guidelines that recommend participating in moderate 
or vigorous PA at least 5 days/week.  Indeed, participating in more frequent bouts of PA has 
been associated with lower mortality risk compared to acquiring the recommended amount of 
weekly PA over 1 or 2 days 
153
, likely due to the acute positive metabolic responses associated 
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with PA 
95
.  These findings indicate that a greater effort may be needed to get very old adults to 
participate in regular PA.   
It has been suggested that PA guidelines should make a greater effort to target physically 
inactive individuals as they stand to benefit the most from participating in PA, but that most PA 
guidelines may be discouraging for physically inactive persons 
209
.  Adults who are physically 
inactive report greater barriers to PA participation, including a lack of knowledge, skills and 
resources regarding PA, and a greater prevalence of comorbid conditions that make PA difficult, 
such as cancer or obesity 
209
.  The Japanese government has recently been praised for their 
innovate messaging about PA and health 
210
.  Although the government recommends 60 
minutes/day of moderate to vigorous PA, they also recommend starting with at least 10 
minutes/day of PA as a minimal starting dose of PA for individuals who engage in no physical 
activity 
211
. Given that only 15% of Canadian adults and 10% of U.S. adults meet the PA 
guidelines based on objective measures of PA 
212,213
, including a minimum PA dose that may be 
more attainable for physically inactive individuals may be a more promising way to increase PA 
at a population level.  However, there is not yet a clear consensus on an optimal minimal dose of 
PA, and the effectiveness of such PA messaging needs to be validated.   
Physical activity is one of the key recommendations for lifestyle intervention for the 
management of both T2D and hypertension 
120,159
.  This dissertation demonstrated the 
importance of PA for mortality risk in adults with T2D or hypertension, even when either disease 
is pharmacologically treated or controlled.  However, adults with hypertension who were active, 
treated and controlled still had a higher mortality risk compared to adults without hypertension 
who participated in PA.  Thus, prevention of hypertension, which can be partially accomplished 
through regular participation in PA, may be imperative for reducing the risk of premature all-
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cause mortality in adults.   Future research should focus on effective methods for increasing PA 
participation in adults with T2D and hypertension.   
Although individuals with chronic disease, such as hypertension or T2D, benefit from PA 
207
, they are less likely be physically active than adults without chronic conditions 
214,215
.  One 
public health approach to increasing PA among individuals at risk for chronic disease is for 
physicians to prescribe PA in primary care 
216
.  While there is some evidence to suggest that this 
may be associated with a modest increase in PA at least in the short term 
217,218
, overall there is 
limited evidence to suggest that a formal PA prescription translates to increased PA in 
populations at risk for chronic disease 
216
.  While prescription of PA in primary care is promising 
in theory, further long-term research is needed to understand if PA prescriptions are indeed 
effective at increasing PA, and how this may influence risk of chronic disease.  
During the past several decades there has been a substantial increase in the prevalence of 
overweight and obesity in individuals of all ages 
219,220
.  This is concerning given the myriad of 
health conditions associated with overweight and obesity 
37
.  It is suggested that the greater 
prevalence of obesity is largely due to individuals consuming significantly more energy than 
they are expending 
221
.  For example, in order for females to have gone from a mean BMI of 23 
kg/m² in the 1970’s to 29 kg/m² in 2002 (Brown et al., unpublished data, Appendix B), it is 
estimated this would have required an energy surplus of 370 kcal/day 
187
.  Furthermore, Hill 
(2003) has suggested that a lower energy intake of just 100 kcal/day could prevent weight gain in 
most of the population 
221
.  However, in order for individuals to successfully lower energy 
intake, it is important to have an understanding of the number of calories that are consumed.  
While the few studies that investigated this concept generally report that individuals tend to 
overestimate energy expenditure and underestimate energy intake 
76,81
, results from this 
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dissertation demonstrate that there was a large individual variability in the accuracy of calorie 
estimation of both exercise and food.  This research is also the first to demonstrate that there may 
be a greater error in calorie estimation among adults who are overweight and not attempting 
weight loss compared to individuals with overweight who are attempting weight loss, and 
individuals with normal weight regardless of weight loss status.  These findings may help 
explain why it is so difficult to lose weight or manage body weight through diet and exercise.  
Future research should investigate effective methods for improving knowledge of energy intake 
and expenditure.   
Despite public health efforts to combat against the rising prevalence of obesity, no 
country has been able to successfully lower obesity rates at a population level 
194
.  Food 
consumed from restaurants make up one third of the American diet, and is associated with a 
higher fat and caloric intake 
222
.  The United States government recently implemented legislation 
that requires restaurants with greater than 20 locations to post calorie information on their menus 
188
.  Although many adults report noticing the calorie menu labels, this does not necessarily 
translate to using the labels to guide meal selection, or purchasing meals with fewer calories 
223
.  
There is some evidence that calorie menu labels may be more likely to be used by females and 
individuals with higher education 
180,223
.  However, there is conflicting evidence as to whether 
this policy has led to customers actually purchasing lower calorie meals 
189,223,224
.  It was 
suggested that calorie labeling alone may not be meaningful if individuals do not understand 
what calories mean, or how the calorie content of an individual meal fits into their total daily 
caloric intake 
222
.  As a result, recent studies have explored how PA equivalent labeling (ie. the 
amount of PA needed to burn off the calories associated with a given meal) may influence meal 
selection 
222
.  However, evidence on the effectiveness of such menu labeling is scarce and more 
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research is in this area is needed.  Thus, while calorie menu labeling may allow for greater 
informed choice when purchasing meals, there is insufficient evidence to suggest that this will 
impact food selection.    
 While general obesity has substantially increased during the past several decades, so too 
has the prevalence of abdominal obesity as assessed by WC 
8
.  Although BMI and WC are highly 
correlated 
55
, WC may be particularly useful in a clinical setting when patients have abdominal 
obesity but not an obese BMI, and thus may still be at a higher risk for weight-related health 
conditions 
225
.  Measurement of WC among the general public is also beneficial, particularly 
since exercise without caloric restriction can lower WC even when there is not a meaningful 
change in overall body weight or BMI 
226
.  Despite the fact that WC is a simple and reproducible 
measurement 
61
, only 17% of a sample of North American adults reported having their WC 
measured in primary care 
201
, and only 1% reported that they measure their own WC 
201
.  Clearly 
greater effort may be needed to educate the general public about the potential value of WC self-
measurement.   
 Despite international health organizations recommending WC measurement 
5,57
, there is 
no standard protocol for measuring WC.  It has been suggested that the commonly recommended 
WC measurement sites, the iliac crest (recommended by Health Canada) and the midpoint 
(recommended by the World Health Organization) may be the easiest sites to measure due to the 
use of bony landmarks 
227
.  Interestingly, research from this dissertation represents the first to 
determine that these sites are moderately more difficult to self-measure compared to the 
umbilicus and minimal waist.  However, overall none of the WC measurement sites were 
reported to be particularly difficult to self-measure, and the majority of participants indicated that 
they would be willing to self-measure their own WC.  As well, the association between WC and 
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blood pressure between the various measurement sites did not differ either statistically, or 
clinically.  However, similar to other studies, the magnitude of WC and the prevalence of 
abdominal obesity differed significantly according to WC measurement site 
62,65
.  Thus, although 
there was no clear clinical or practical advantage of measuring one site over another, in order for 
the magnitude of WC and prevalence of abdominal obesity to be comparable between research 
studies, a standard measurement protocol is needed. 
 In conclusion, both physical inactivity and obesity are highly prevalent and associated 
with increased risk of morbidity and mortality.  Even modest amounts of PA are effective for 
reducing mortality risk, and may be particularly beneficial in the elderly and among adults with 
T2D or hypertension.   Targeted efforts are needed to increase PA among these populations.  In 
addition, many individuals are attempting to lose weight, but most are unable to lose weight and 
maintain that weight loss over a long term. Therefore, effective methods for long term weight 
management are also needed.  
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Appendices 
 
Appendix A: Example of Instructions Given to Participants for Waist Circumference 
Measurement 
 
Stand relaxed with your feet should width apart (25-30 cm or 10-12 inches) in front of a mirror 
and remove any clothing that would interfere with measuring your waist circumference.  Put the 
tape measure around your waist directly on your skin.   
 
 
Use the mirror to ensure that you have placed the tape measure correctly (ie. Horizontally, and 
not twisted or caught on clothing).  Relax, press the button, and take the waist measurement at 
the end of a normal expiration to the closet 0.5 cm.   
 
 
 
 
 
 
 
 
 
 
 Hip Bones 
Last Rib 
Midpoint 
 
  
 
    
 
  
  
Use your hands to find the middle between your rib bones and hip 
bones on both sides of your body.   
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